Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	benzodiazepine receptor binding	RIMBP3C RIMBP3 RIMBP3B	3.59e-05	5	309	3	GO:0030156
GeneOntologyMolecularFunction	cell adhesion molecule binding	PFKP SVEP1 EPS15L1 F11R AHNAK PKM PKP2 TLN2 CNTN2 FLNA ANK3 DSC2 DOCK9 ICAM2 GRIN2B TJP1 TLN1 CD40LG DCHS1 MACF1 CDH4 HCFC1	1.74e-04	599	309	22	GO:0050839
GeneOntologyMolecularFunction	(R)-limonene 6-monooxygenase activity	CYP2C19 CYP2C9	2.39e-04	2	309	2	GO:0052741
GeneOntologyMolecularFunction	(S)-limonene 6-monooxygenase activity	CYP2C19 CYP2C9	2.39e-04	2	309	2	GO:0018675
GeneOntologyMolecularFunction	(S)-limonene 7-monooxygenase activity	CYP2C19 CYP2C9	2.39e-04	2	309	2	GO:0018676
GeneOntologyMolecularFunction	limonene monooxygenase activity	CYP2C19 CYP2C9	2.39e-04	2	309	2	GO:0019113
GeneOntologyMolecularFunction	cadherin binding	PFKP EPS15L1 F11R AHNAK PKM PKP2 FLNA ANK3 DOCK9 TJP1 TLN1 DCHS1 MACF1 CDH4 HCFC1	2.79e-04	339	309	15	GO:0045296
GeneOntologyMolecularFunction	1-phosphatidylinositol-4-phosphate 5-kinase activity	PIP5KL1 PIP5K1A PIP5K1B	2.88e-04	9	309	3	GO:0016308
GeneOntologyMolecularFunction	1-phosphatidylinositol-3-phosphate 5-kinase activity	PIP5K1A PIP5K1B	7.09e-04	3	309	2	GO:0000285
GeneOntologyMolecularFunction	1-phosphatidylinositol-5-kinase activity	PIP5K1A PIP5K1B	7.09e-04	3	309	2	GO:0052810
GeneOntologyMolecularFunction	6-phosphofructokinase activity	PFKM PFKP	7.09e-04	3	309	2	GO:0003872
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	ERBB4 GAK PFKM PFKP MAST2 MAP3K1 JAK2 PASK STRADA PIP5KL1 PKM PIP5K1A PIP5K1B PPP1R9B CCL8 OXSR1 MERTK NTRK1 MST1R N4BP2 GUCY2D PRKG1 PEAK1	7.15e-04	709	309	23	GO:0016773
GeneOntologyBiologicalProcess	cell-cell adhesion	TRO NPHP4 SVEP1 BLM JAK2 FAT2 PTPRC HMCN2 F11R PTPRS PKD1 PKP2 COL14A1 TLN2 SDK1 CNTN2 SELPLG FLNA ANK3 DSC2 FAT3 ICAM2 PCDH11Y PELI1 CELSR3 TJP1 ARID2 TLN1 CD40LG CD44 DCHS1 IGSF9B PRKG1 NFAT5 MUC4 CDH4	4.33e-06	1077	305	36	GO:0098609
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	TRO FAT2 HMCN2 PKD1 SDK1 CNTN2 DSC2 FAT3 PCDH11Y CELSR3 DCHS1 IGSF9B CDH4	4.51e-06	187	305	13	GO:0007156
GeneOntologyBiologicalProcess	cell junction organization	ERBB4 MYO9A NPHP4 ZDHHC8 SVEP1 HMCN2 F11R SNAP91 PTPRS PKP2 PIP5K1A TLN2 PPP1R9B SDK1 CNTN2 FLNA ANK3 NTRK1 GRIN2B ARHGAP39 REST APOE ADNP TJP1 TLN1 CNTNAP4 MACF1 ADGRE5 TMEM108 IGSF9B PEAK1 PATJ CDH4	8.48e-06	974	305	33	GO:0034330
GeneOntologyBiologicalProcess	endocytosis	GAK ZFYVE16 EPS15L1 PTPRC ALMS1 AP2A2 AP2B1 SNAP91 PIP5K1A PLA2G6 C4A C4B MERTK HEATR5B CNTN2 PCSK9 HSPG2 LRP12 BIN1 ANK3 PSTPIP1 APOE MST1R TGM2 NECAP2 CD44 TMEM108 XKR5	4.28e-05	827	305	28	GO:0006897
GeneOntologyCellularComponent	anchoring junction	DCAF6 IL16 GAK MAST2 NPHP4 JAK2 FAT2 PTPRC F11R AHNAK SYNE2 PKP2 PIP5K1A TLN2 PPP1R9B AMOTL2 HSPG2 FLNA ANK3 DSC2 TGM2 AFAP1 LLGL1 TJP1 TLN1 MDC1 ENAH CD44 ADGRE5 PEAK1 ATP1A2 PATJ CDH4	9.48e-06	976	310	33	GO:0070161
GeneOntologyCellularComponent	focal adhesion	DCAF6 IL16 GAK JAK2 PTPRC AHNAK SYNE2 PIP5K1A TLN2 HSPG2 FLNA TGM2 AFAP1 TLN1 MDC1 ENAH CD44 ADGRE5 PEAK1	2.63e-05	431	310	19	GO:0005925
GeneOntologyCellularComponent	cell-substrate junction	DCAF6 IL16 GAK JAK2 PTPRC AHNAK SYNE2 PIP5K1A TLN2 HSPG2 FLNA TGM2 AFAP1 TLN1 MDC1 ENAH CD44 ADGRE5 PEAK1	3.81e-05	443	310	19	GO:0030055
GeneOntologyCellularComponent	uropod	PIP5K1B SELPLG ICAM2 PSTPIP1	4.22e-05	14	310	4	GO:0001931
GeneOntologyCellularComponent	cell trailing edge	PIP5K1B SELPLG ICAM2 PSTPIP1	5.69e-05	15	310	4	GO:0031254
GeneOntologyCellularComponent	clathrin coat	EPS15L1 AP2A2 AP2B1 SNAP91 NECAP2 AP4B1	1.76e-04	56	310	6	GO:0030118
GeneOntologyCellularComponent	dendrite	ERBB4 ANKS1B PGR KCNH1 COBL PPP1R9B C4A C4B PLCB4 FLNA BIN1 ANK3 RASGRF1 NTRK1 FAT3 LAMA2 GRIA4 GRIN2B APOE ADNP CNTNAP4 TMEM108 IGSF9B ATP1A2 HCFC1 CPEB1 KIF1C	2.06e-04	858	310	27	GO:0030425
GeneOntologyCellularComponent	dendritic tree	ERBB4 ANKS1B PGR KCNH1 COBL PPP1R9B C4A C4B PLCB4 FLNA BIN1 ANK3 RASGRF1 NTRK1 FAT3 LAMA2 GRIA4 GRIN2B APOE ADNP CNTNAP4 TMEM108 IGSF9B ATP1A2 HCFC1 CPEB1 KIF1C	2.14e-04	860	310	27	GO:0097447
GeneOntologyCellularComponent	Golgi lumen	MUC17 MUC20 HSPG2 MUC19 MUC16 VCAN MUC1 MUC4	2.22e-04	109	310	8	GO:0005796
GeneOntologyCellularComponent	clathrin coat of coated pit	EPS15L1 AP2A2 AP2B1 SNAP91	2.33e-04	21	310	4	GO:0030132
GeneOntologyCellularComponent	axon	MYO9A PGR HMCN2 SNAP91 PTPRS KCNH1 SCN9A COBL PPP1R9B C4A C4B MGARP USH2A CNTN2 FLNA BIN1 ANK3 RASGRF1 NTRK1 GRIA4 GRIN2B ADNP LLGL1 TMEM108 HCFC1 CPEB1 KIF1C	3.73e-04	891	310	27	GO:0030424
GeneOntologyCellularComponent	postsynaptic density	ERBB4 ANKS1B RUSC1 SNAP91 PTPRS KCNH1 PPP1R9B PLCB4 ANK3 GRIA4 GRIN2B GRIN2C CELSR3 MACF1 TMEM108 IGSF9B CPEB1	4.42e-04	451	310	17	GO:0014069
GeneOntologyCellularComponent	cell-cell contact zone	AHNAK PKP2 TLN2 ANK3 DSC2 TJP1 ATP1A2	5.01e-04	94	310	7	GO:0044291
GeneOntologyCellularComponent	intercalated disc	PKP2 TLN2 ANK3 DSC2 TJP1 ATP1A2	5.13e-04	68	310	6	GO:0014704
GeneOntologyCellularComponent	postsynapse	ERBB4 MYO9A ANKS1B RUSC1 ZDHHC8 PGR JAK2 AP2A2 AP2B1 SNAP91 PTPRS KCNH1 PPP1R9B PLCB4 CNTN2 FLNA BIN1 ANK3 LAMA2 GRIA4 GRIN2B GRIN2C ARHGAP39 CELSR3 MACF1 TMEM108 IGSF9B ATP1A2 CPEB1	6.17e-04	1018	310	29	GO:0098794
GeneOntologyCellularComponent	6-phosphofructokinase complex	PFKM PFKP	6.51e-04	3	310	2	GO:0005945
GeneOntologyCellularComponent	asymmetric synapse	ERBB4 ANKS1B RUSC1 SNAP91 PTPRS KCNH1 PPP1R9B PLCB4 ANK3 GRIA4 GRIN2B GRIN2C CELSR3 MACF1 TMEM108 IGSF9B CPEB1	8.26e-04	477	310	17	GO:0032279
GeneOntologyCellularComponent	nuclear body	MAGEA4 IL16 HIVEP1 ANKS1B NPHP4 FBXL4 BLM SCNM1 TELO2 PRPF40B PIP5K1A PLA2G6 HEATR5B RAD51 AFF2 ZCCHC8 LARS1 PRPF40A PALB2 PPP1R8 ATF7IP MDC1 SAFB2 DNAAF1 EPAS1 SON	1.01e-03	903	310	26	GO:0016604
GeneOntologyCellularComponent	extrinsic component of plasma membrane	TRAF3IP2 JAK2 AP2B1 SNAP91 PCSK9 APOE DCHS1 CDH4	1.02e-03	137	310	8	GO:0019897
GeneOntologyCellularComponent	AP-2 adaptor complex	AP2A2 AP2B1 SNAP91	1.04e-03	14	310	3	GO:0030122
GeneOntologyCellularComponent	clathrin adaptor complex	AP2A2 AP2B1 SNAP91 AP4B1	1.09e-03	31	310	4	GO:0030131
GeneOntologyCellularComponent	clathrin-coated endocytic vesicle membrane	KIAA0319 AP2A2 AP2B1 SNAP91 SLC2A8 APOE	1.14e-03	79	310	6	GO:0030669
GeneOntologyCellularComponent	clathrin-coated pit	EPS15L1 AP2A2 AP2B1 SNAP91 LRP12 NECAP2	1.21e-03	80	310	6	GO:0005905
GeneOntologyCellularComponent	clathrin coat of endocytic vesicle	AP2A2 AP2B1 SNAP91	1.29e-03	15	310	3	GO:0030128
GeneOntologyCellularComponent	extrinsic component of external side of plasma membrane	PCSK9 APOE	1.29e-03	4	310	2	GO:0031232
GeneOntologyCellularComponent	early endosome membrane	STAM2 ZFYVE16 PLD3 KIAA0319 KCNH1 NTRK1 UBXN6 WDR91 WASH3P LLGL1	1.31e-03	212	310	10	GO:0031901
GeneOntologyCellularComponent	somatodendritic compartment	ERBB4 ANKS1B PGR HMCN2 SNAP91 PTPRS KCNH1 COBL PPP1R9B C4A C4B PLCB4 USH2A CNTN2 FLNA BIN1 ANK3 RASGRF1 NTRK1 FAT3 LAMA2 GRIA4 GRIN2B APOE ADNP CNTNAP4 TMEM108 IGSF9B ATP1A2 HCFC1 CPEB1 KIF1C	1.43e-03	1228	310	32	GO:0036477
GeneOntologyCellularComponent	postsynaptic specialization	ERBB4 ANKS1B RUSC1 SNAP91 PTPRS KCNH1 PPP1R9B PLCB4 ANK3 GRIA4 GRIN2B GRIN2C CELSR3 MACF1 TMEM108 IGSF9B CPEB1	1.46e-03	503	310	17	GO:0099572
GeneOntologyCellularComponent	clathrin-coated vesicle membrane	KIAA0319 AP2A2 AP2B1 SNAP91 SLC2A8 APOE NECAP2 AP4B1	1.61e-03	147	310	8	GO:0030665
GeneOntologyCellularComponent	neuron to neuron synapse	ERBB4 ANKS1B RUSC1 SNAP91 PTPRS KCNH1 PPP1R9B PLCB4 ANK3 GRIA4 GRIN2B GRIN2C CELSR3 MACF1 TMEM108 IGSF9B CPEB1	2.21e-03	523	310	17	GO:0098984
GeneOntologyCellularComponent	clathrin vesicle coat	AP2A2 AP2B1 SNAP91 NECAP2	2.35e-03	38	310	4	GO:0030125
GeneOntologyCellularComponent	postsynaptic density membrane	ERBB4 PTPRS KCNH1 GRIA4 GRIN2B GRIN2C CELSR3 TMEM108	2.43e-03	157	310	8	GO:0098839
GeneOntologyCellularComponent	collagen-containing extracellular matrix	IL16 SMOC1 HMCN2 MUC17 PKM COL14A1 USH2A HSPG2 RARRES2 LAMA2 APOE TGM2 EYS VCAN MUC1 MUC4 HCFC1	2.53e-03	530	310	17	GO:0062023
GeneOntologyCellularComponent	meiotic spindle	PNMA5 CPEB1 BORA	2.62e-03	19	310	3	GO:0072687
GeneOntologyCellularComponent	clathrin-coated vesicle	GAK KIAA0319 AP2A2 AP2B1 SNAP91 HEATR5B SLC2A8 APOE NECAP2 AP4B1	2.95e-03	237	310	10	GO:0030136
GeneOntologyCellularComponent	actin-based cell projection	MUC17 SYNE2 PPP1R9B USH2A MUC20 ICAM2 WASH3P ENAH CD44 MUC4 CEACAM20	3.05e-03	278	310	11	GO:0098858
GeneOntologyCellularComponent	endolysosome membrane	AP2A2 AP2B1 PCSK9	3.05e-03	20	310	3	GO:0036020
GeneOntologyCellularComponent	node of Ranvier	CNTN2 BIN1 ANK3	3.05e-03	20	310	3	GO:0033268
GeneOntologyCellularComponent	interphotoreceptor matrix	EYS VCAN	3.16e-03	6	310	2	GO:0033165
GeneOntologyCellularComponent	neuronal cell body	ERBB4 PGR HMCN2 SNAP91 PTPRS KCNH1 COBL PPP1R9B C4A C4B USH2A CNTN2 FLNA RASGRF1 NTRK1 GRIA4 GRIN2B APOE ADNP IGSF9B ATP1A2 HCFC1 CPEB1	3.40e-03	835	310	23	GO:0043025
Domain	FN3_dom	KIAA0319 IGSF22 PTPRC PTPRS COL14A1 RIMBP3C MERTK USH2A SDK1 CNTN2 FSD2 RIMBP3 ATF7IP CNTN3 IGSF9B RIMBP3B HCFC1	5.78e-08	209	303	17	IPR003961
Domain	LAM_G_DOMAIN	FAT2 USH2A HSPG2 FAT3 LAMA2 EYS CELSR3 CNTNAP4	1.40e-07	38	303	8	PS50025
Domain	FN3	IGSF22 PTPRC PTPRS COL14A1 RIMBP3C MERTK USH2A SDK1 CNTN2 FSD2 RIMBP3 ATF7IP CNTN3 IGSF9B RIMBP3B HCFC1	1.67e-07	199	303	16	PS50853
Domain	Ig-like_fold	KIAA0319 IGSF22 PTPRC HMCN2 F11R PTPRS PXDNL VSIG10L COL14A1 RIMBP3C ADGRF5 CAMTA1 MERTK USH2A SDK1 CNTN2 HSPG2 FLNA NTRK1 ICAM2 FSD2 RIMBP3 MST1R TGM2 ATF7IP VCAN CNTN3 IGSF9B RIMBP3B NFAT5 CEACAM20 HCFC1	1.68e-07	706	303	32	IPR013783
Domain	Laminin_G_2	FAT2 USH2A HSPG2 FAT3 LAMA2 EYS CELSR3 CNTNAP4	2.14e-07	40	303	8	PF02210
Domain	Laminin_G	FAT2 COL14A1 USH2A HSPG2 FAT3 LAMA2 EYS CELSR3 CNTNAP4	3.67e-07	58	303	9	IPR001791
Domain	FN3	KIAA0319 IGSF22 PTPRC PTPRS COL14A1 RIMBP3C MERTK USH2A SDK1 CNTN2 FSD2 CNTN3 IGSF9B RIMBP3B HCFC1	3.67e-07	185	303	15	SM00060
Domain	-	IGSF22 PTPRC F11R PTPRS PXDNL VSIG10L COL14A1 RIMBP3C ADGRF5 CAMTA1 MERTK USH2A SDK1 CNTN2 HSPG2 FLNA NTRK1 ICAM2 FSD2 RIMBP3 MST1R TGM2 ATF7IP VCAN CNTN3 IGSF9B RIMBP3B NFAT5 CEACAM20 HCFC1	4.34e-07	663	303	30	2.60.40.10
Domain	LamG	FAT2 USH2A HSPG2 FAT3 LAMA2 EYS CELSR3 CNTNAP4	4.67e-07	44	303	8	SM00282
Domain	SEA	MUC17 ADGRF5 HSPG2 MUC16 MUC1	1.93e-06	14	303	5	SM00200
Domain	-	ADGRG4 SVEP1 FAT2 USH2A HSPG2 FAT3 LAMA2 EYS CELSR3 CNTNAP4	3.26e-06	95	303	10	2.60.120.200
Domain	Ig_I-set	IGSF22 HMCN2 F11R PTPRS PXDNL ADGRF5 MERTK SDK1 CNTN2 HSPG2 CNTN3 IGSF9B CEACAM20	1.42e-05	190	303	13	IPR013098
Domain	I-set	IGSF22 HMCN2 F11R PTPRS PXDNL ADGRF5 MERTK SDK1 CNTN2 HSPG2 CNTN3 IGSF9B CEACAM20	1.42e-05	190	303	13	PF07679
Domain	GPS	ADGRG4 PKD1 ADGRF5 CELSR3 ADGRG2 ADGRE5	1.59e-05	34	303	6	SM00303
Domain	GPS	ADGRG4 PKD1 ADGRF5 CELSR3 ADGRG2 ADGRE5	1.89e-05	35	303	6	PF01825
Domain	GPS	ADGRG4 PKD1 ADGRF5 CELSR3 ADGRG2 ADGRE5	2.24e-05	36	303	6	PS50221
Domain	SEA	MUC17 ADGRF5 HSPG2 MUC16 MUC1	2.28e-05	22	303	5	PF01390
Domain	GPS	ADGRG4 PKD1 ADGRF5 CELSR3 ADGRG2 ADGRE5	2.64e-05	37	303	6	IPR000203
Domain	SEA	MUC17 ADGRF5 HSPG2 MUC16 MUC1	2.88e-05	23	303	5	PS50024
Domain	SEA_dom	MUC17 ADGRF5 HSPG2 MUC16 MUC1	2.88e-05	23	303	5	IPR000082
Domain	EGF-like_dom	PGAP6 SVEP1 FAT2 HMCN2 MUC17 HSPG2 FAT3 LAMA2 EYS CELSR3 VCAN CNTNAP4 ADGRE5 MUC4	5.96e-05	249	303	14	IPR000742
Domain	fn3	IGSF22 PTPRC PTPRS COL14A1 MERTK USH2A SDK1 CNTN2 FSD2 CNTN3 IGSF9B	6.97e-05	162	303	11	PF00041
Domain	EGF_1	PGAP6 SVEP1 FAT2 HMCN2 MUC17 USH2A HSPG2 FAT3 LAMA2 EYS CELSR3 VCAN CNTNAP4 MUC4	7.69e-05	255	303	14	PS00022
Domain	-	MUC17 ADGRF5 MUC16 MUC1	8.05e-05	15	303	4	3.30.70.960
Domain	WW	PRPF40B WWP1 FNBP4 ARHGAP39 PRPF40A CEP164	1.20e-04	48	303	6	SM00456
Domain	EGF	PGAP6 SVEP1 FAT2 MUC17 HSPG2 FAT3 LAMA2 EYS CELSR3 VCAN CNTNAP4 ADGRE5 MUC4	1.28e-04	235	303	13	SM00181
Domain	IGc2	IGSF22 HMCN2 F11R PTPRS PXDNL VSIG10L ADGRF5 SDK1 CNTN2 HSPG2 CNTN3 IGSF9B CEACAM20	1.28e-04	235	303	13	SM00408
Domain	EGF_3	PGAP6 SVEP1 FAT2 HMCN2 MUC17 HSPG2 FAT3 EYS CELSR3 VCAN CNTNAP4 ADGRE5 MUC4	1.28e-04	235	303	13	PS50026
Domain	Ig_sub2	IGSF22 HMCN2 F11R PTPRS PXDNL VSIG10L ADGRF5 SDK1 CNTN2 HSPG2 CNTN3 IGSF9B CEACAM20	1.28e-04	235	303	13	IPR003598
Domain	PInositol-4-P-5-kinase	PIP5KL1 PIP5K1A PIP5K1B	1.41e-04	7	303	3	IPR023610
Domain	WW_DOMAIN_1	PRPF40B WWP1 FNBP4 ARHGAP39 PRPF40A CEP164	1.69e-04	51	303	6	PS01159
Domain	WW_DOMAIN_2	PRPF40B WWP1 FNBP4 ARHGAP39 PRPF40A CEP164	1.69e-04	51	303	6	PS50020
Domain	EGF_CA	SVEP1 FAT2 HMCN2 HSPG2 FAT3 EYS CELSR3 VCAN ADGRE5	1.70e-04	122	303	9	SM00179
Domain	WW_dom	PRPF40B WWP1 FNBP4 ARHGAP39 PRPF40A CEP164	1.89e-04	52	303	6	IPR001202
Domain	EGF-like_Ca-bd_dom	SVEP1 FAT2 HMCN2 HSPG2 FAT3 EYS CELSR3 VCAN ADGRE5	1.92e-04	124	303	9	IPR001881
Domain	GPCR_2_secretin-like_CS	ADGRG4 ADGRF5 CELSR3 ADGRG2 ADGRE5	2.06e-04	34	303	5	IPR017983
Domain	PIP5K	PIP5KL1 PIP5K1A PIP5K1B	2.23e-04	8	303	3	PF01504
Domain	PIPK	PIP5KL1 PIP5K1A PIP5K1B	2.23e-04	8	303	3	PS51455
Domain	-	PIP5KL1 PIP5K1A PIP5K1B	2.23e-04	8	303	3	3.30.810.10
Domain	PIPKc	PIP5KL1 PIP5K1A PIP5K1B	2.23e-04	8	303	3	SM00330
Domain	-	PIP5KL1 PIP5K1A PIP5K1B	2.23e-04	8	303	3	3.30.800.10
Domain	PInositol-4-P-5-kinase_N	PIP5KL1 PIP5K1A PIP5K1B	2.23e-04	8	303	3	IPR027484
Domain	PInositol-4-P-5-kinase_C	PIP5KL1 PIP5K1A PIP5K1B	2.23e-04	8	303	3	IPR027483
Domain	Coatomer/calthrin_app_sub_C	AP2A2 AP2B1 AP4B1	2.23e-04	8	303	3	IPR009028
Domain	PInositol-4-P-5-kinase_core	PIP5KL1 PIP5K1A PIP5K1B	2.23e-04	8	303	3	IPR002498
Domain	ConA-like_dom	ADGRG4 SVEP1 FAT2 COL14A1 USH2A HSPG2 FAT3 LAMA2 FSD2 EYS CELSR3 CNTNAP4	2.53e-04	219	303	12	IPR013320
Domain	-	TLN2 TLN1	2.62e-04	2	303	2	1.20.1420.10
Domain	VBS	TLN2 TLN1	2.62e-04	2	303	2	PF08913
Domain	Talin_cent	TLN2 TLN1	2.62e-04	2	303	2	IPR015224
Domain	Talin_middle	TLN2 TLN1	2.62e-04	2	303	2	PF09141
Domain	Vinculin-bd_dom	TLN2 TLN1	2.62e-04	2	303	2	IPR015009
Domain	EGF-like_CS	PGAP6 SVEP1 FAT2 HMCN2 MUC17 HSPG2 FAT3 LAMA2 EYS CELSR3 VCAN CNTNAP4 MUC4	3.57e-04	261	303	13	IPR013032
Domain	EGF_2	PGAP6 SVEP1 FAT2 HMCN2 MUC17 HSPG2 FAT3 LAMA2 EYS CELSR3 VCAN CNTNAP4 MUC4	4.13e-04	265	303	13	PS01186
Domain	PAS_9	PASK KCNH1 KCNH3	4.66e-04	10	303	3	PF13426
Domain	Laminin_G_1	HSPG2 LAMA2 EYS	6.33e-04	11	303	3	PF00054
Domain	Cadherin	KIAA0319 FAT2 DSC2 FAT3 PCDH11Y CELSR3 DCHS1 CDH4	6.84e-04	118	303	8	IPR002126
Domain	NMDAR2_C	GRIN2B GRIN2C	7.79e-04	3	303	2	PF10565
Domain	Phosphofructokinase_CS	PFKM PFKP	7.79e-04	3	303	2	IPR015912
Domain	PFK	PFKM PFKP	7.79e-04	3	303	2	PF00365
Domain	B2-adapt-app_C	AP2B1 AP4B1	7.79e-04	3	303	2	PF09066
Domain	Phosphofructokinase_dom	PFKM PFKP	7.79e-04	3	303	2	IPR000023
Domain	6-Pfructokinase_euk	PFKM PFKP	7.79e-04	3	303	2	IPR009161
Domain	AP_complex_bsu_1_2_4	AP2B1 AP4B1	7.79e-04	3	303	2	IPR016342
Domain	PHOSPHOFRUCTOKINASE	PFKM PFKP	7.79e-04	3	303	2	PS00433
Domain	Talin-1	TLN2 TLN1	7.79e-04	3	303	2	IPR015710
Domain	ATP_PFK	PFKM PFKP	7.79e-04	3	303	2	IPR022953
Domain	NMDAR2_C	GRIN2B GRIN2C	7.79e-04	3	303	2	IPR018884
Domain	WW	PRPF40B WWP1 FNBP4 ARHGAP39 PRPF40A	9.55e-04	47	303	5	PF00397
Domain	EGF	SVEP1 FAT2 HSPG2 EYS CELSR3 VCAN CNTNAP4 MUC4	1.05e-03	126	303	8	PF00008
Domain	ASX_HYDROXYL	SVEP1 HMCN2 FAT3 EYS CELSR3 VCAN ADGRE5	1.22e-03	100	303	7	PS00010
Domain	G_PROTEIN_RECEP_F2_2	ADGRG4 ADGRF5 CELSR3 ADGRG2 ADGRE5	1.27e-03	50	303	5	PS00650
Domain	7tm_2	ADGRG4 ADGRF5 CELSR3 ADGRG2 ADGRE5	1.27e-03	50	303	5	PF00002
Domain	EGF_LAM_2	USH2A HSPG2 LAMA2 CELSR3	1.33e-03	30	303	4	PS50027
Domain	EGF_LAM_1	USH2A HSPG2 LAMA2 CELSR3	1.33e-03	30	303	4	PS01248
Domain	IG	IGSF22 HMCN2 F11R PTPRS PXDNL VSIG10L ADGRF5 MERTK SDK1 CNTN2 HSPG2 NTRK1 VCAN CNTN3 IGSF9B CEACAM20	1.50e-03	421	303	16	SM00409
Domain	Ig_sub	IGSF22 HMCN2 F11R PTPRS PXDNL VSIG10L ADGRF5 MERTK SDK1 CNTN2 HSPG2 NTRK1 VCAN CNTN3 IGSF9B CEACAM20	1.50e-03	421	303	16	IPR003599
Domain	-	PRPF40B PRPF40A	1.54e-03	4	303	2	1.10.10.440
Domain	FERM_f0	TLN2 TLN1	1.54e-03	4	303	2	PF16511
Domain	ILWEQ	TLN2 TLN1	1.54e-03	4	303	2	PD011820
Domain	B2-adapt-app_C	AP2B1 AP4B1	1.54e-03	4	303	2	SM01020
Domain	I_LWEQ	TLN2 TLN1	1.54e-03	4	303	2	PF01608
Domain	I_LWEQ	TLN2 TLN1	1.54e-03	4	303	2	PS50945
Domain	FERM_f0	TLN2 TLN1	1.54e-03	4	303	2	IPR032425
Domain	B-adaptin_app_sub_C	AP2B1 AP4B1	1.54e-03	4	303	2	IPR015151
Domain	ILWEQ_dom	TLN2 TLN1	1.54e-03	4	303	2	IPR002558
Domain	ILWEQ	TLN2 TLN1	1.54e-03	4	303	2	SM00307
Domain	-	TLN2 TLN1	1.54e-03	4	303	2	1.20.1410.10
Domain	Adaptin_N	AP2A2 AP2B1 AP4B1	1.66e-03	15	303	3	PF01602
Domain	Clathrin/coatomer_adapt-like_N	AP2A2 AP2B1 AP4B1	1.66e-03	15	303	3	IPR002553
Domain	SH3_9	RUSC1 RIMBP3C BIN1 PSTPIP1 RIMBP3 RIMBP3B	1.67e-03	78	303	6	PF14604
Domain	PAS	PASK KCNH1 KCNH3 EPAS1	1.71e-03	32	303	4	SM00091
Domain	EGF-type_Asp/Asn_hydroxyl_site	SVEP1 HMCN2 FAT3 EYS CELSR3 VCAN ADGRE5	1.71e-03	106	303	7	IPR000152
Domain	Cadherin_CS	FAT2 DSC2 FAT3 PCDH11Y CELSR3 DCHS1 CDH4	2.01e-03	109	303	7	IPR020894
Domain	IQ	DCAF6 MYO9A SCN9A CAMTA1 IQCH RASGRF1	2.03e-03	81	303	6	SM00015
Domain	PAS	PASK KCNH1 KCNH3 EPAS1	2.15e-03	34	303	4	PS50112
Domain	PAS	PASK KCNH1 KCNH3 EPAS1	2.15e-03	34	303	4	IPR000014
Domain	MAGE	MAGEA4 TRO MAGEC1 MAGEC2	2.15e-03	34	303	4	SM01373
Domain	EGF_Lam	USH2A HSPG2 LAMA2 CELSR3	2.39e-03	35	303	4	SM00180
Domain	Laminin_EGF	USH2A HSPG2 LAMA2 CELSR3	2.39e-03	35	303	4	PF00053
Domain	CADHERIN_1	FAT2 DSC2 FAT3 PCDH11Y CELSR3 DCHS1 CDH4	2.46e-03	113	303	7	PS00232
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC17 MUC20 MUC19 MUC16 MUC1 MUC4	6.02e-07	21	220	6	MM15706
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC17 MUC20 MUC16 MUC1 MUC4	3.36e-06	16	220	5	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC17 MUC20 MUC16 MUC1 MUC4	4.70e-06	17	220	5	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC17 MUC20 MUC16 MUC1 MUC4	2.37e-05	23	220	5	M556
Pathway	REACTOME_GLUCOSE_METABOLISM	PFKM PFKP ENO4 PKM RANBP2 NUP214 NUP133 NUP188	4.10e-05	82	220	8	MM15394
Pathway	REACTOME_DECTIN_2_FAMILY	MUC17 MUC20 MUC16 MUC1 MUC4	4.45e-05	26	220	5	M27483
Pathway	REACTOME_GLUCOSE_METABOLISM	PFKM PFKP ENO4 PKM RANBP2 NUP214 NUP133 NUP188	5.31e-05	85	220	8	M1870
Pathway	REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS	STAM2 GAK KIAA0319 EPS15L1 AP2A2 AP2B1 SNAP91 BIN1 SLC2A8 NECAP2	7.72e-05	142	220	10	MM15499
Pathway	REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS	STAM2 GAK KIAA0319 EPS15L1 AP2A2 AP2B1 SNAP91 BIN1 SLC2A8 NECAP2	9.20e-05	145	220	10	M27753
Pathway	REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS	STAM2 KIAA0319 EPS15L1 AP2A2 AP2B1 SNAP91 SLC2A8 NECAP2	1.93e-04	102	220	8	MM15498
Pathway	REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS	STAM2 KIAA0319 EPS15L1 AP2A2 AP2B1 SNAP91 SLC2A8 NECAP2	2.36e-04	105	220	8	M27752
Pathway	REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES	PTPRS GRIA4 GRIN2B GRIN2C	2.80e-04	21	220	4	M27736
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC17 MUC20 MUC19 MUC16 MUC1 MUC4	3.35e-04	60	220	6	MM15636
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ZHX3 STAM2 GAK ILF3 ZNF148 ZFYVE16 NACA PFKM PFKP ANKHD1 EPS15L1 SAFB R3HCC1L ALMS1 AP2B1 AHNAK PKM PPP1R9B RPRD2 TACC1 PRRC2A NOL8 FLNA RANBP2 ZCCHC8 LARS1 YTHDC2 NUP214 ADNP PRPF40A EEF1B2 RBM12 TJP1 ATF7IP ARID2 TLN1 ENAH FAM169A NUP133 SAFB2 ANKRD17 MACF1 HCFC1 SON	5.55e-19	934	318	44	33916271
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ZHX3 HIVEP1 ILF3 ZNF148 ITPRID2 PHF8 PFKP BLM PASK EPS15L1 SAFB PTPRC TLN2 OXSR1 PRRC2A MED13 MOCOS FOXM1 FLNA RANBP2 BIN1 ZCCHC8 FNBP4 YTHDC2 NUP214 ARHGAP39 REST PRPF40A PALB2 PACS1 EEF1B2 MDC1 SAFB2 ANKRD17 ELF1 SNAPC4 SON	2.73e-16	774	318	37	15302935
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	STAM2 GAK ZNF148 PHF8 ANKHD1 RUVBL2 KMT2C EPS15L1 ALMS1 AHNAK PKM RPRD2 AMOTL2 PRRC2A FLNA ANK3 FNBP4 APOE ADNP PRPF40A TJP1 ARID2 TLN1 MDC1 ENAH PEAK1 PATJ HCFC1	2.92e-13	549	318	28	38280479
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	IL16 GAK ILF3 MYO9A ANKS1B PFKM PLD3 PFKP IGLV8-61 EPS15L1 SAFB AP2A2 AP2B1 SNAP91 PTPRS GLUD2 PKM TLN2 PPP1R9B C4A C4B PRRC2A IMMT CNTN2 FLNA BIN1 ANK3 PRR36 WDR7 LARS1 YTHDC2 GRIN2B ARHGAP39 APOE PRPF40A PACS1 EEF1B2 AFAP1 TJP1 VCAN TLN1 MACF1 PEAK1 ATP1A2	2.17e-12	1431	318	44	37142655
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	VWA8 ANKHD1 MAST2 NPHP4 ZDHHC8 FANCA JAK2 KMT2C EPS15L1 PTPRS AHNAK PKD1 MTMR3 COBL TLN2 PLA2G6 DOCK6 MED13 RAD51 HSPG2 FLNA WWP1 DOCK9 NUP214 NUBPL C8orf58 KCNH3 MST1R CELSR3 ZNF827 TTLL4 TLN1 ANKRD11 NUP188 SNAPC4 MFSD5 HCFC1	1.30e-11	1105	318	37	35748872
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	PFKP ANKHD1 BLM PNPT1 AP2B1 AHNAK SYNE2 PRRC2A IMMT PHIP FLNA RANBP2 ZCCHC8 YTHDC2 NUP214 ADNP PRPF40A PELP1 TJP1 TLN1 MDC1 NUP133 ANKRD17 MACF1 NUP188 HCFC1 AQR SON	1.80e-11	653	318	28	22586326
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	VWA8 MAST2 KIAA0319 ALMS1 KATNIP MED13 FNBP4 RBM12 CELSR3 CNTNAP4 MACF1 BICRAL CEP152 NFAT5	1.81e-11	130	318	14	12421765
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	VWA8 NACA GMEB2 ANKHD1 PASK KMT2C TELO2 RPRD2 OXSR1 AMOTL2 DOCK6 MED13 JADE2 LARS1 FNBP4 ADNP AFAP1 RBM12 CELSR3 TTLL4 MDC1 ANKRD17 NUP188 ATP1A2 PADI2	2.94e-11	529	318	25	14621295
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ZHX3 HIVEP1 ILF3 ZNF148 SALL3 BLM EPS15L1 SAFB SNAP91 AHNAK RPRD2 PRRC2A IMMT PHIP NOL8 FLNA RANBP2 FNBP4 ZDBF2 NUP214 ADNP PRPF40A EEF1B2 PELP1 TJP1 ATF7IP ARID2 MDC1 ANKRD11 SAFB2 MPHOSPH8 HCFC1 SON	7.81e-11	954	318	33	36373674
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DCAF6 MYO9A RABGAP1 PLD3 JAK2 KMT2C PCYOX1L TSC22D1 EPS15L1 ATXN1 PTPRS COBL PIP5K1A PPP1R9B PLA2G6 KATNIP RPRD2 PLCB4 OXSR1 CAMTA1 DOCK6 MOCOS PRUNE2 VPS37A ANK3 JADE2 WWP1 PCDH11Y FNBP4 ARHGAP39 LRRC8D PACS1 ZNF827 TJP1 ENAH ANKRD11 ANKRD17 MACF1 IGSF9B GREB1 PATJ NFAT5	1.07e-10	1489	318	42	28611215
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ERBB4 DCAF6 IL16 ZNF148 VWA8 PHF8 ANKHD1 MAST2 RUVBL2 PASK HMCN2 ALMS1 TELO2 PRPF40B ATXN1 PKP2 PHIP DSC2 ZCCHC8 WWP1 FAT3 YTHDC2 NUBPL PRPF40A KAT7 ZNF827 ARID2 PNMA2 ANKRD17 MACF1 BICRAL TRAF3IP3 NUP188 PADI2 SON	2.80e-10	1116	318	35	31753913
Pubmed	Functional proteomics mapping of a human signaling pathway.	STAM2 HIVEP1 ZFYVE16 SVEP1 PTPRC AP2A2 PKD1 PKP2 PPP1R9B MERTK SDK1 HSPG2 FLNA ANK3 ZCCHC8 WWP1 FNBP4 PRPF40A PPP1R8 TGM2 PELP1 ATF7IP MACF1 EPAS1 SON	3.00e-10	591	318	25	15231748
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ILF3 ANKS1B KIAA0319 EPS15L1 AP2A2 AP2B1 SNAP91 PTPRS SYNE2 TLN2 PPP1R9B PRRC2A RANBP2 BIN1 ANK3 PRR36 WDR7 GRIA4 GRIN2B ARHGAP39 ADNP WDR91 FAM171A2 PELP1 TJP1 N4BP2 ATF7IP ENAH DCHS1 SAFB2 ANKRD17 MACF1	4.18e-10	963	318	32	28671696
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	ILF3 NACA ITPRID2 PLD3 PFKP RUVBL2 SAFB F11R AHNAK SYNE2 PKM HEATR5B IMMT PHIP FLNA RANBP2 LARS1 YTHDC2 NUP214 ADNP PRPF40A NCOA5 EEF1B2 PELP1 TJP1 TLN1 MDC1 NUP133 SAFB2 MACF1 NUP188 AQR SON	4.75e-10	1024	318	33	24711643
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	ZHX3 STAM2 ILF3 ZNF148 ZFYVE16 NACA PFKM BLM SAFB AP2B1 TLN2 RPRD2 TACC1 DNAJC2 EEF1B2 AFAP1 NECAP2 LLGL1 ARID2 CD44 MACF1 MPHOSPH8	6.06e-10	472	318	22	38943005
Pubmed	A human MAP kinase interactome.	HIVEP1 MYO9A ITPRID2 KMT2C TSC22D1 AP2B1 ATXN1 COBL C4A FLNA RANBP2 ANK3 JADE2 NUP214 N4BP2 ATF7IP ARID2 ANKRD17 MACF1 BICRAL MUC1 EPAS1	1.04e-09	486	318	22	20936779
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CCP110 SP2 NPHP4 LCMT2 TSC22D1 FAT2 ALMS1 AP2A2 ADGRF5 PRUNE2 ARHGAP39 SLC45A4 NCOA5 N4BP2 ARID2 FAM169A SAFB2 CNTNAP4 MACF1 CEP152 PEAK1 KIF1C	1.36e-09	493	318	22	15368895
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	CCP110 ILF3 ZNF148 PFKP BLM EPS15L1 SAFB PKM TLN2 RPRD2 PRRC2A MOCOS FLNA RANBP2 ZCCHC8 KAT7 ENAH NUP133 ELF1 HCFC1 SON KIF1C	1.96e-09	503	318	22	16964243
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CCP110 STAM2 ERBB4 HIVEP1 MYO9A ITPRID2 PFKP MAST2 RUSC2 ALMS1 ATXN1 AHNAK SYNE2 PKP2 COBL DOCK6 DSC2 ZCCHC8 FAM171A2 TJP1 N4BP2 ANKRD11 ANKRD17 MACF1 CEP152 PEAK1 PATJ AQR KIF1C	2.13e-09	861	318	29	36931259
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	HIVEP1 ZNF148 ZFYVE16 RUSC1 RABGAP1 ANKHD1 ALMS1 AHNAK RAD51 FLNA RANBP2 ZCCHC8 ZDBF2 POU5F1 NUP214 ADNP PALB2 N4BP2 ATF7IP ANKRD17	2.38e-09	418	318	20	34709266
Pubmed	EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation.	ZNF148 PFKP RUVBL2 PKM PPP1R9B IMMT ADNP TJP1 NUP133 ANKRD11 HCFC1 SON	2.56e-09	128	318	12	23858473
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	STAM2 ILF3 ZFYVE16 MYO9A RUVBL2 EPS15L1 AHNAK PKM PKP2 PRRC2A IMMT RANBP2 ANK3 DSC2 LARS1 YTHDC2 NUP214 ARHGAP39 PRPF40A LLGL1 TLN1 ANKRD17 MACF1 PEAK1 PATJ HCFC1	2.58e-09	708	318	26	39231216
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	ILF3 NACA ITPRID2 RUVBL2 SAFB AP2A2 AP2B1 AHNAK PPP1R9B IMMT FLNA RANBP2 NUP214 PRPF40A KAT7 PPP1R8 TGM2 AFAP1 TJP1 MDC1 CD44 NUP133 SAFB2 MACF1 NUP188	2.85e-09	660	318	25	32780723
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ZHX3 PHF8 PASK KMT2C ALMS1 AP2A2 SYNE2 TLN2 RPRD2 CAMTA1 PRUNE2 DOCK9 RBM12 TLN1 MACF1	3.05e-09	225	318	15	12168954
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	STAM2 GAK ILF3 ZNF148 VWA8 ITPRID2 PFKM PLD3 PFKP LCMT2 BLM PASK PNPT1 R3HCC1L TELO2 SYNE2 PIP5K1A COL14A1 TACC1 SUCO IMMT NOL8 ANK3 DSC2 NDUFAF2 FNBP4 SCAMP2 PRPF40A DNAJC2 MRPS7 LLGL1 FAM171A2 N4BP2 TLN1 NUP133 ANKRD11 MACF1 PEAK1 AQR	4.03e-09	1487	318	39	33957083
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	SP2 ILF3 ZNF148 GMEB2 BLM EPS15L1 SAFB AHNAK PKM OXSR1 FOXM1 FLNA RANBP2 VPS37A ADNP PRPF40A RBM12 TJP1 TLN1 HCFC1	6.62e-09	444	318	20	34795231
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	DCAF6 HIVEP1 MAST2 ALMS1 ATXN1 NFE2L1 SYNE2 PKM COL14A1 MED13 HSPG2 RANBP2 BIN1 WWP1 DOCK9 LAMA2 FSD2 TLN1 NUP133 MACF1 SON	8.42e-09	497	318	21	23414517
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC17 MUC20 MUC19 MUC16 MUC1 MUC4	9.43e-09	18	318	6	18834073
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MAGEA4 ILF3 MYO9A NACA PHF8 PFKM PFKP ANKHD1 RUVBL2 BLM SAFB AP2A2 AP2B1 AHNAK PKM PKP2 IMMT PHIP FLNA RANBP2 LARS1 NUP214 ADNP KAT7 MRPS7 TGM2 EEF1B2 LLGL1 TLN1 MDC1 NUP133 SAFB2 ANKRD17 MACF1 AQR SON	1.17e-08	1353	318	36	29467282
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	ERBB4 TRO ITPRID2 MAP3K1 AP2B1 NFE2L1 OXSR1 CAMTA1 PRUNE2 AFF2 ANK3 NUP214 ADNP ARID2 TLN1 MDC1 IGSF9B PATJ SON	2.16e-08	430	318	19	35044719
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	ERBB4 VWA8 NACA ANKS1B RABGAP1 RUVBL2 EPS15L1 SAFB AP2A2 GLUD2 PKM TLN2 PPP1R9B TACC1 FLNA RANBP2 BIN1 ANK3 DOCK9 GRIA4 ZDBF2 GRIN2B ARHGAP39 MRPS7 EEF1B2 FAM171A2 TJP1 ENAH FAM169A MACF1 PEAK1 ATP1A2	2.32e-08	1139	318	32	36417873
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	TRAF3IP2 PKM TLN2 TACC1 PLCB4 CAMTA1 PRRC2A MED13 FBXO34 NDUFAF2 FNBP4 REST LRRC8D PPP1R8 ARID2 TTLL4 ENAH ANKRD11 ELF1 CEP152 PEAK1	3.08e-08	536	318	21	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	TRAF3IP2 PKM TLN2 TACC1 PLCB4 CAMTA1 PRRC2A MED13 FBXO34 NDUFAF2 FNBP4 REST LRRC8D PPP1R8 ARID2 TTLL4 ENAH ANKRD11 ELF1 CEP152 PEAK1	3.28e-08	538	318	21	10512203
Pubmed	An investigation into the human serum "interactome".	TSC22D1 TLN2 CACNA1I C4A CAMTA1 MOCOS RANBP2 APOE PALB2 FAM169A SAFB2 MACF1	3.67e-08	162	318	12	15174051
Pubmed	Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	TRO PHF8 ANKHD1 TACC1 OXSR1 DOCK9 CEP164 TLN1 IGSF9B SON	4.33e-08	104	318	10	10470851
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZHX3 ZFYVE16 TRO PHF8 RUSC2 KIAA0319 MTMR3 COBL KATNIP CAMTA1 WDR7 DOCK9 NUP214 TLN1 MACF1 NFAT5 AQR SON	5.04e-08	407	318	18	12693553
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	CCP110 STAM2 ZNF148 KMT2C ALMS1 AHNAK PHIP RANBP2 ZCCHC8 NUP214 REST KAT7 PELP1 N4BP2 NUP133 MUC4 HCFC1 HYDIN AQR	8.45e-08	469	318	19	27634302
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	PFKM PFKP SAFB AHNAK PKM FLNA RANBP2 LARS1 NUP214 PELP1 ATF7IP ARID2 TLN1 MDC1 SAFB2 HCFC1	8.81e-08	332	318	16	32786267
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	ILF3 ZNF148 RUVBL2 SAFB COBL C4A PRRC2A NOL8 RANBP2 JADE2 ZCCHC8 FNBP4 PRPF40A NCOA5 KAT7 EEF1B2 PELP1 TJP1 ARID2 MDC1 NUP133 SAFB2 ANKRD17 NFAT5 AQR SON	9.42e-08	847	318	26	35850772
Pubmed	Molecular and functional characterization of clathrin- and AP-2-binding determinants within a disordered domain of auxilin.	GAK AP2A2 AP2B1 SNAP91	1.01e-07	6	318	4	12732633
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	GAK ZFYVE16 PFKM PFKP ANKHD1 PASK AP2B1 TELO2 PTPRS MTMR3 PIP5K1A ANKMY2 OXSR1 PRRC2A IMMT FLNA RANBP2 YTHDC2 NUP214 MRPS7 EEF1B2 TJP1 PNMA2 NUP133 ANKRD17 NUP188 CDC25A PADI2	1.15e-07	974	318	28	28675297
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	ILF3 NACA ITPRID2 RUVBL2 FANCA BLM SAFB AHNAK PKM C4B IMMT FLNA RANBP2 ADNP PRPF40A NCOA5 PELP1 TLN1 MDC1 SAFB2 HCFC1 SON	1.94e-07	652	318	22	31180492
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	ZHX3 BLM KMT2C SCN9A COBL C4A C4B PLCB4 ANK3 DOCK9 FNBP4 YTHDC2 NUP214 APOE ARID2 ANKRD11 MUC4 HCFC1 HYDIN	2.06e-07	497	318	19	36774506
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	MAGEA4 ILF3 NACA ITPRID2 PFKP RUVBL2 SAFB AP2B1 AHNAK PKM PKP2 PPP1R9B IMMT NOL8 FLNA LARS1 YTHDC2 ADNP DNAJC2 NCOA5 MRPS7 TGM2 EEF1B2 AFAP1 PELP1 TJP1 MDC1 NUP133 SAFB2 ANKRD17 PATJ AQR	2.16e-07	1257	318	32	36526897
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	ZHX3 ILF3 RABGAP1 PHF8 PFKP RUVBL2 BLM SAFB AHNAK OXSR1 IMMT MAGEC2 MED13 RANBP2 ADNP PRPF40A NCOA5 KAT7 PPP1R8 EEF1B2 RBM12 MDC1 NUP133 SAFB2 MPHOSPH8 HCFC1 AQR SON	2.59e-07	1014	318	28	32416067
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	ILF3 NACA MAST2 NFE2L1 TACC1 PRRC2A RANBP2 YTHDC2 REST LLGL1 CDC25A SON BORA	2.63e-07	232	318	13	25515538
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	ZFYVE16 ITPRID2 PFKP EPS15L1 F11R AHNAK VSIG10L PKM PKP2 FLNA ANK3 DOCK9 NUP214 LLGL1 TJP1 TLN1 MACF1 PEAK1 PATJ HCFC1	3.34e-07	565	318	20	25468996
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	HIVEP1 ILF3 NACA PFKM ANKHD1 MAST2 RUVBL2 SAFB AP2A2 PKM TLN2 IMMT PHIP FLNA RANBP2 LARS1 YTHDC2 SCAMP2 NUP214 ADNP PRPF40A NCOA5 EEF1B2 PELP1 TLN1 MDC1 ENAH NUP133 SAFB2 MPHOSPH8 NUP188 PEAK1 HCFC1 AQR	3.93e-07	1425	318	34	30948266
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	ILF3 RUVBL2 BLM AP2A2 AP2B1 AHNAK COBL RPRD2 PRRC2A FLNA ZCCHC8 PRPF40A PELP1 MDC1 HCFC1	6.85e-07	340	318	15	24332808
Pubmed	Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.	MUC16 MUC1 MUC4	7.57e-07	3	318	3	23053434
Pubmed	Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.	MUC16 MUC1 MUC4	7.57e-07	3	318	3	24939955
Pubmed	Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).	MUC16 MUC1 MUC4	7.57e-07	3	318	3	27483328
Pubmed	Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma.	MUC16 CD44 MUC1	7.57e-07	3	318	3	12893366
Pubmed	Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.	MUC16 MUC1 MUC4	7.57e-07	3	318	3	17592322
Pubmed	Genetic contribution of CYP2C9, CYP2C19, and APOE variants in acenocoumarol response.	CYP2C19 CYP2C9 APOE	7.57e-07	3	318	3	24222221
Pubmed	Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.	MUC16 MUC1 MUC4	7.57e-07	3	318	3	35879412
Pubmed	Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.	MUC20 MUC16 MUC4	7.57e-07	3	318	3	30236127
Pubmed	Expression of mucin (MUC) genes in mucoepidermoid carcinoma.	MUC19 MUC1 MUC4	7.57e-07	3	318	3	21072847
Pubmed	Comparative phenotypic analysis of the two major splice isoforms of phosphatidylinositol phosphate kinase type Iγ in vivo.	PIP5K1A PIP5K1B TLN2 TLN1	8.34e-07	9	318	4	22976293
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	FAT2 PTPRS LIPG C4A ADGRF5 MERTK CNTN2 HSPG2 DSC2 ICAM2 LAMA2 CD44 CNTN3	8.39e-07	257	318	13	16335952
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	ILF3 NACA ITPRID2 PFKM PFKP RUVBL2 BLM ALMS1 AP2B1 AHNAK PKM FLNA LARS1 NUP214 EEF1B2 TLN1 NUP133 HCFC1	8.63e-07	494	318	18	26831064
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	ILF3 VWA8 PLD3 RUVBL2 BLM PNPT1 SAFB AP2B1 PKM DOCK6 RANBP2 WDR7 ZCCHC8 FNBP4 ARHGAP39 ADNP PRPF40A NCOA5 AFAP1 LLGL1 TJP1 ARID2 VCAN SAFB2 MACF1 MPHOSPH8 AQR SON	9.36e-07	1082	318	28	38697112
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	ILF3 VWA8 NACA PFKM PFKP ANKHD1 RUVBL2 PNPT1 AP2A2 AP2B1 AHNAK SYNE2 PKM PRRC2A IMMT FLNA RANBP2 LARS1 FNBP4 LRRC8D DNAJC2 MRPS7 EEF1B2 PELP1 TJP1 TLN1 MDC1 ENAH MACF1 HCFC1 AQR SON KIF1C	9.73e-07	1415	318	33	28515276
Pubmed	Human transcription factor protein interaction networks.	ZHX3 SP2 HIVEP1 ZNF148 NACA GMEB2 PHF8 PFKP ANKHD1 RUVBL2 BLM KMT2C ALMS1 ATXN1 SYNE2 RPRD2 PRRC2A IMMT HSPG2 LARS1 NUP214 ADNP PRPF40A MRPS7 RBM12 ATF7IP ARID2 MDC1 ANKRD17 ELF1 CEP152 HCFC1 CPEB1	1.20e-06	1429	318	33	35140242
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SP2 ILF3 ZNF148 PHF8 RUVBL2 FANCA BLM KMT2C SAFB AHNAK RPRD2 NOL8 RANBP2 ZCCHC8 FNBP4 NUP214 REST ADNP PRPF40A PALB2 NCOA5 KAT7 PELP1 MDC1 NUP133 ANKRD11 SAFB2 MPHOSPH8 NUP188 HCFC1 SON	1.22e-06	1294	318	31	30804502
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	GAK VWA8 NACA ITPRID2 PFKM PLD3 PFKP ZBP1 AP2A2 AP2B1 TELO2 AHNAK SYNE2 COBL PRRC2A FLNA RANBP2 JADE2 ZCCHC8 LARS1 YTHDC2 NUBPL KAT7 MRPS7 EEF1B2 AFAP1 PELP1 TLN1 MDC1 CD44 NUP133 NUP188 HCFC1	1.42e-06	1440	318	33	30833792
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	HIVEP1 ZNF148 MAST2 SAFB HMCN2 TLN2 PRRC2A ANK3 DSC2 RASGRF1 YTHDC2 CELSR3 MDC1 MACF1 SON	1.44e-06	361	318	15	26167880
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	ILF3 RUVBL2 BLM AHNAK RPRD2 NOL8 FLNA RANBP2 PSTPIP1 EEF1B2 MDC1 HCFC1 AQR	1.52e-06	271	318	13	32433965
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	ZDHHC8 F11R PKP2 COBL DSC2 NDUFAF2 WWP1 DOCK9 UBXN6 SCAMP2 NUBPL LRRC8D PACS1 PIEZO2 LLGL1 FAM171A2 CD44 PEAK1 PATJ	1.56e-06	569	318	19	30639242
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	STAM2 ZFYVE16 ITPRID2 PHF8 BLM PTPRC TELO2 PTPRS AHNAK SYNE2 MTMR3 PPP1R9B PRRC2A RANBP2 ANK3 ARHGAP39 NCOA5 PPP1R8 PACS1 FAM171A2 TJP1 ENAH PNMA2 CD44 NUP133 PEAK1 CDC25A	1.63e-06	1049	318	27	27880917
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	ILF3 PFKM PFKP RUVBL2 PNPT1 AP2A2 AP2B1 PKM PKP2 OXSR1 AMOTL2 PRRC2A IMMT MED13 RAD51 FLNA RANBP2 WWP1 LARS1 NUP214 APOE PRPF40A EEF1B2 TJP1 TLN1 ANKRD17 PATJ NFAT5 HCFC1 AQR	1.67e-06	1247	318	30	27684187
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	STAM2 DCAF6 NACA RABGAP1 SMOC1 PFKM PLD3 PFKP RUVBL2 TSC22D1 EPS15L1 AP2B1 TELO2 AHNAK PKM ANKMY2 OXSR1 RAD51 PRUNE2 FLNA BIN1 LARS1 TGM2 EEF1B2 RBM12 TLN1 ENAH PNMA2 CD44 NUP133 MACF1 NUP188 HCFC1	1.78e-06	1455	318	33	22863883
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	CCP110 ILF3 MAST2 FAT2 AHNAK FLNA FAT3 PRPF40A EEF1B2 PELP1 MDC1 MACF1	1.92e-06	234	318	12	36243803
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	ANKS1B AP2A2 AP2B1 AHNAK PIP5KL1 TLN2 PPP1R9B ANK3 WDR7 GRIN2B ARHGAP39 ENAH MACF1	2.26e-06	281	318	13	28706196
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	PFKP RUVBL2 EPS15L1 SAFB PTPRC AP2B1 PKM PPP1R9B OXSR1 PRRC2A IMMT RANBP2 ZCCHC8 LARS1 FNBP4 YTHDC2 DNAJC2 TLN1 SAFB2 MPHOSPH8 HCFC1	2.45e-06	701	318	21	30196744
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CCP110 STAM2 GAK HIVEP1 MYO9A RABGAP1 ITPRID2 RUVBL2 BLM ALMS1 FOXM1 ZCCHC8 ZDBF2 RIMBP3 N4BP2 ATF7IP ARID2 MACF1 PATJ	2.52e-06	588	318	19	38580884
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	TRAF3IP2 NACA ANKHD1 MAST2 RUVBL2 RUSC2 FANCA PIP5K1A C4A C4B MOCOS YTHDC2 PACS1 TGM2 LLGL1 ANKRD17 AP4B1 PATJ HCFC1 AQR	2.86e-06	650	318	20	38777146
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	GAK ILF3 VWA8 SAFB PRRC2A IMMT RANBP2 FNBP4 PELP1 ATP1A2 AQR	2.90e-06	202	318	11	24639526
Pubmed	Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase.	HIVEP1 ILF3 MAST2 TACC1 REST TJP1 CDC25A HCFC1 BORA	2.93e-06	128	318	9	25332235
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	SALL3 ANKHD1 LCMT2 KMT2C PTPRC NFE2L1 KCNH1 CAMTA1 SUCO FLNA ANK3 WWP1 DOCK9 PHTF2 KAT7 PACS1 ZNF750 VCAN TTLL4 SAFB2 ANKRD17 MACF1 ADGRE5 NUP188 PEAK1 PATJ NFAT5	3.00e-06	1084	318	27	11544199
Pubmed	B cells drive lymphocyte activation and expansion in mice with the CD45 wedge mutation and Fas deficiency.	PTPRC C4A C4B	3.01e-06	4	318	3	19001138
Pubmed	TRPV4 activation in human corneal epithelial cells promotes membrane mucin production.	MUC16 MUC1 MUC4	3.01e-06	4	318	3	39024979
Pubmed	Integrative brain transcriptome analysis links complement component 4 and HSPA2 to the APOE ε2 protective effect in Alzheimer disease.	C4A C4B APOE	3.01e-06	4	318	3	34480088
Pubmed	RIM-BP3 is a manchette-associated protein essential for spermiogenesis.	RIMBP3C RIMBP3 RIMBP3B	3.01e-06	4	318	3	19091768
Pubmed	Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon.	MUC17 MUC1 MUC4	3.01e-06	4	318	3	18198997
Pubmed	Loss of PIP5KIgamma, unlike other PIP5KI isoforms, impairs the integrity of the membrane cytoskeleton in murine megakaryocytes.	PIP5K1A PIP5K1B TLN1	3.01e-06	4	318	3	18188447
Pubmed	Identification and characterization of a phosphoinositide phosphate kinase homolog.	PIP5KL1 PIP5K1A PIP5K1B	3.01e-06	4	318	3	14701839
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	ILF3 MYO9A NACA PHF8 PFKP AP2A2 AP2B1 PKM PRRC2A YTHDC2 PRPF40A KAT7 LLGL1 TJP1 ARID2 TTLL4 ATP1A2	3.01e-06	486	318	17	30940648
Pubmed	Tagging genes with cassette-exchange sites.	ZNF148 KMT2C SAFB OXSR1 WDR7 DOCK9 REST PRPF40A NCOA5 KAT7 ENAH SAFB2 MACF1 AQR	3.03e-06	335	318	14	15741177
Pubmed	KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.	SAFB AHNAK RPRD2 ZCCHC8 ADNP PRPF40A RBM12 SAFB2 SON	3.34e-06	130	318	9	35545047
Pubmed	Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.	RUVBL2 FAAH AHNAK RPRD2 PHIP RANBP2 PRPF40A NCOA5 MDC1 NUP133 SAFB2 CEP152 NUP188 SON	3.59e-06	340	318	14	29478914
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	ILF3 BLM PKP2 RPRD2 RANBP2 FNBP4 YTHDC2 NUP214 ADNP PELP1 ARID2 MDC1 NUP133 ANKRD17 NUP188 AQR	3.61e-06	440	318	16	34244565
Pubmed	Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell Migration.	EPS15L1 AHNAK FLNA LLGL1 TJP1 CD44	3.84e-06	46	318	6	35022314
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	CCP110 MYO9A PASK ALMS1 COBL YTHDC2 ZDBF2 AFAP1 MACF1 CEP152 PEAK1	4.02e-06	209	318	11	36779422
Pubmed	Defining the membrane proteome of NK cells.	GAK ILF3 PFKP PCYOX1L EPS15L1 PTPRC AP2B1 AHNAK HEATR5B PRRC2A IMMT MED13 FLNA RANBP2 DOCK9 ICAM2 PSTPIP1 APOE LRRC8D PRPF40A PELP1 NUP133 ANKRD17 ADGRE5 NUP188 MFSD5 HCFC1 AQR	4.03e-06	1168	318	28	19946888
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	CCP110 STAM2 RUVBL2 MAP3K1 FBXL4 RUSC2 PASK EPS15L1 AP2B1 TELO2 STRADA KATNIP RPRD2 AMOTL2 HEATR5B DOCK6 MOCOS VPS37A ZCCHC8 WDR91 KAT7 TJP1 TTLL4 ENAH AP4B1 BORA	4.17e-06	1038	318	26	26673895
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	CCP110 MAST2 RUVBL2 ALMS1 AP2A2 MTMR3 PKP2 PPP1R9B AMOTL2 DOCK6 ZCCHC8 TJP1 PNMA2 CEP152 PATJ KIF1C	4.28e-06	446	318	16	24255178
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	NACA EPS15L1 AHNAK PKM FLNA RANBP2 ZDBF2 NUP214 TJP1 TLN1 ANKRD17 HCFC1	4.85e-06	256	318	12	33397691
Pubmed	A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway.	TRO SMOC1 ALMS1 AP2A2 TELO2 AHNAK OXSR1 PRRC2A RANBP2 VPS37A PELI1 CEP164 DNAAF1	4.96e-06	302	318	13	30561431
Pubmed	The nuclear localization pattern and interaction partners of GTF2IRD1 demonstrate a role in chromatin regulation.	DCAF6 SCNM1 ALMS1 PKP2 AKIRIN2 ATF7IP	6.31e-06	50	318	6	26275350
Interaction	NAA40 interactions	ZHX3 STAM2 GAK ILF3 ZNF148 ZFYVE16 NACA PFKM PFKP ANKHD1 EPS15L1 SAFB R3HCC1L ALMS1 AP2B1 AHNAK PKM PPP1R9B RPRD2 TACC1 PRRC2A NOL8 FLNA RANBP2 ZCCHC8 LARS1 YTHDC2 NUP214 ADNP PRPF40A EEF1B2 RBM12 TJP1 ATF7IP ARID2 TLN1 ENAH FAM169A NUP133 SAFB2 ANKRD17 MACF1 HCFC1 SON	1.58e-10	978	310	44	int:NAA40
Interaction	TOP3B interactions	VWA8 PFKP ANKHD1 MAST2 NPHP4 ZDHHC8 FANCA JAK2 KMT2C EPS15L1 SAFB PTPRS AHNAK PKD1 MTMR3 PKP2 COBL TLN2 PPP1R9B PLA2G6 DOCK6 PRRC2A IMMT MED13 RAD51 HSPG2 FLNA WWP1 DOCK9 LARS1 NUP214 NUBPL C8orf58 KCNH3 MST1R MRPS7 CELSR3 PELP1 ZNF827 TTLL4 TLN1 MDC1 PNMA2 ANKRD11 SAFB2 ANKRD17 NUP188 SNAPC4 MFSD5 HCFC1	9.20e-08	1470	310	50	int:TOP3B
Interaction	PIP5K1C interactions	AP2A2 AP2B1 PKD1 PIP5KL1 PIP5K1A PIP5K1B TLN2 TLN1	8.77e-07	50	310	8	int:PIP5K1C
Interaction	VCL interactions	CCP110 ZFYVE16 PASK ALMS1 SNAP91 PKD1 IMMT PHIP NTRK1 PRPF40A MST1R LLGL1 TJP1 N4BP2 TLN1 ENAH MACF1 PEAK1	1.30e-06	305	310	18	int:VCL
Interaction	KCNA3 interactions	STAM2 IL16 ILF3 ZFYVE16 MYO9A NACA PFKM RUVBL2 KMT2C EPS15L1 AHNAK PKM PKP2 COBL TLN2 PRRC2A IMMT RANBP2 AFF2 ANK3 DSC2 LARS1 YTHDC2 NUP214 ARHGAP39 PRPF40A LLGL1 TLN1 ANKRD17 MACF1 PEAK1 PATJ HCFC1	1.85e-06	871	310	33	int:KCNA3
Interaction	CIT interactions	ERBB4 ILF3 VWA8 NACA PFKM PFKP RUVBL2 SAFB ALMS1 AP2A2 AP2B1 AHNAK SYNE2 PKP2 CACNA1I OXSR1 PRRC2A IMMT PHIP RAD51 FLNA RANBP2 YTHDC2 GRIN2B ADNP PRPF40A NCOA5 KAT7 EEF1B2 PELP1 TJP1 MDC1 CD44 NUP133 SAFB2 CNTNAP4 MACF1 ELF1 MPHOSPH8 NUP188 PATJ CDC25A HCFC1 AQR SON	5.18e-06	1450	310	45	int:CIT
Interaction	YWHAH interactions	CCP110 STAM2 HIVEP1 ILF3 MYO9A ITPRID2 MAST2 RUSC2 ALMS1 ATXN1 AHNAK SYNE2 MTMR3 PKP2 COBL PPP1R9B AMOTL2 DOCK6 SUCO DSC2 ZCCHC8 NTRK1 DOCK9 MST1R PACS1 FAM171A2 TJP1 ANKRD11 ANKRD17 MACF1 CEP152 PEAK1 PATJ CDC25A AQR CPEB1 KIF1C	7.01e-06	1102	310	37	int:YWHAH
Interaction	RPA4 interactions	NACA PFKM ANKHD1 RUVBL2 BLM SAFB AHNAK RPRD2 PRRC2A NOL8 FLNA RANBP2 NUP214 ADNP PRPF40A EEF1B2 TJP1 TLN1 SAFB2 HCFC1 SON	7.69e-06	452	310	21	int:RPA4
Interaction	YWHAG interactions	CCP110 STAM2 HIVEP1 MYO9A ITPRID2 PFKP MAST2 RUVBL2 MAP3K1 RUSC2 JAK2 ALMS1 ATXN1 SYNE2 MTMR3 PKP2 COBL PPP1R9B AMOTL2 SUCO FLNA DSC2 NTRK1 DOCK9 PRPF40A MST1R PACS1 TGM2 FAM171A2 TJP1 N4BP2 ANKRD11 ANKRD17 MACF1 PEAK1 PATJ CDC25A AQR SON KIF1C	8.71e-06	1248	310	40	int:YWHAG
Interaction	KDM1A interactions	IL16 HIVEP1 ZNF148 ZFYVE16 RUSC1 RABGAP1 PHF8 ANKHD1 RUVBL2 ZBP1 ALMS1 ATXN1 AHNAK TACC1 IMMT RAD51 FLNA RANBP2 VPS37A ZCCHC8 NTRK1 ZDBF2 POU5F1 NUP214 ADNP PALB2 ZNF750 PELP1 N4BP2 ATF7IP ANKRD17 CEP152 EPAS1	9.43e-06	941	310	33	int:KDM1A
Interaction	WWTR1 interactions	STAM2 IL16 GAK ANKHD1 RUVBL2 EPS15L1 ALMS1 RPRD2 AMOTL2 PRRC2A ANK3 ADNP PRPF40A TJP1 ARID2 TLN1 ENAH PEAK1 PATJ HCFC1	9.51e-06	422	310	20	int:WWTR1
Interaction	SIRT7 interactions	PFKP ANKHD1 BLM PNPT1 AP2B1 AHNAK SYNE2 PRRC2A IMMT PHIP FLNA RANBP2 ZCCHC8 YTHDC2 NUP214 ADNP PRPF40A PELP1 TJP1 TLN1 MDC1 NUP133 ANKRD17 MACF1 NUP188 HCFC1 AQR SON	1.31e-05	744	310	28	int:SIRT7
Interaction	NUP43 interactions	HIVEP1 ITPRID2 PHF8 BLM SAFB SYNE2 PHIP RAD51 FLNA RANBP2 LRP12 MUC19 ZDBF2 NUP214 PELP1 ATF7IP ARID2 MDC1 GUCY2D FAM169A NUP133 ANKRD11 ELF1 HCFC1 SON	1.41e-05	625	310	25	int:NUP43
Interaction	SUMO2 interactions	NACA PHF8 PFKM PFKP MAST2 BLM SAFB ATXN1 AHNAK PKM MERTK RAD51 FLNA RANBP2 LARS1 NUP214 PELP1 ZBTB25 ATF7IP ARID2 TLN1 MDC1 SAFB2 HCFC1	1.65e-05	591	310	24	int:SUMO2
Interaction	CUL7 interactions	ILF3 PLD3 PFKP RUVBL2 SAFB KCNH1 AHNAK SYNE2 PKM MAGEC1 DOCK6 PRRC2A IMMT PHIP FLNA RANBP2 UBXN6 NUP214 PRPF40A NCOA5 EEF1B2 PELP1 TJP1 TLN1 MDC1 PNMA2 SAFB2 MACF1 SON KIF1C	1.95e-05	845	310	30	int:CUL7
Interaction	ATG16L1 interactions	CCP110 RABGAP1 PFKP RUVBL2 RUSC2 PASK EPS15L1 SAFB PTPRC AP2B1 PKD1 PKM PKP2 PPP1R9B KATNIP OXSR1 TMEM184B PRRC2A IMMT FLNA RANBP2 ANK3 ZCCHC8 LARS1 FNBP4 YTHDC2 DNAJC2 N4BP2 TTLL4 TLN1 SAFB2 MPHOSPH8 CEP152 TRAF3IP3 SNAPC4 PATJ HCFC1	2.21e-05	1161	310	37	int:ATG16L1
Interaction	AGAP2 interactions	TRO ANKS1B AP2A2 AP2B1 AHNAK PIP5KL1 TLN2 PPP1R9B ANK3 GRIN2B ARHGAP39 ENAH MACF1	2.38e-05	210	310	13	int:AGAP2
Interaction	NECAP1 interactions	AP2A2 AP2B1 SNAP91 PHIP BIN1 KAT7 NECAP2 MDC1	2.64e-05	78	310	8	int:NECAP1
Interaction	HSP90AA1 interactions	TRAF3IP2 ERBB4 ILF3 RABGAP1 MAST2 NPHP4 RUVBL2 PGR FBXL4 FANCA BLM JAK2 PASK STRADA PKM ANKMY2 PPP1R9B C4A MERTK FBXO34 RAD51 FOXM1 HSPG2 FLNA NDUFAF2 NTRK1 WWP1 LARS1 YTHDC2 APOE MST1R LLGL1 TJP1 TLN1 GUCY2D MYOCD MUC1 HCFC1 EPAS1	2.64e-05	1263	310	39	int:HSP90AA1
Interaction	YWHAZ interactions	CCP110 HIVEP1 MYO9A ITPRID2 PFKM PFKP MAST2 MAP3K1 RUSC2 AP2B1 ATXN1 SYNE2 MTMR3 PKP2 PPP1R9B KATNIP SUCO PRRC2A BIN1 DSC2 RASGRF1 WDR7 NTRK1 DOCK9 APOE MST1R PACS1 TGM2 EEF1B2 FAM171A2 TJP1 MDC1 ENAH PNMA2 ANKRD17 MACF1 PEAK1 CDC25A PADI2 KIF1C	3.10e-05	1319	310	40	int:YWHAZ
Interaction	SMC5 interactions	ZHX3 HIVEP1 ILF3 ZNF148 SALL3 BLM EPS15L1 SAFB SNAP91 AHNAK RPRD2 PRRC2A IMMT PHIP NOL8 FLNA RANBP2 FNBP4 ZDBF2 NUP214 ADNP PRPF40A EEF1B2 PELP1 TJP1 ATF7IP ARID2 MDC1 ANKRD11 SAFB2 MPHOSPH8 HCFC1 SON	3.21e-05	1000	310	33	int:SMC5
Interaction	KIF20A interactions	ILF3 VWA8 ITPRID2 RUVBL2 BLM SAFB ALMS1 AP2A2 AP2B1 MUC17 AHNAK SYNE2 PKM PKP2 PIP5K1B PPP1R9B PRRC2A IMMT FLNA RANBP2 PRPF40A PIEZO2 AFAP1 PELP1 TJP1 FER1L4 MDC1 CD44 NUP133 SAFB2 CNTNAP4 MACF1 SNAPC4 SON	3.68e-05	1052	310	34	int:KIF20A
Interaction	RHOB interactions	STAM2 ZFYVE16 MYO9A PFKP ZDHHC8 F11R AP2B1 PTPRS PKP2 COBL PIP5K1A PLCB4 OXSR1 SDK1 IMMT ANK3 DSC2 NDUFAF2 DOCK9 ARHGAP39 LRRC8D LLGL1 FAM171A2 TJP1 CD44 MACF1 ADGRE5 PEAK1 PATJ	4.46e-05	840	310	29	int:RHOB
Interaction	RAC1 interactions	ZFYVE16 PFKM PFKP ZDHHC8 AP2A2 AP2B1 ATXN1 PTPRS PKM PKP2 COBL PIP5K1A PPP1R9B PLCB4 OXSR1 DOCK6 IMMT FLNA BIN1 ANK3 DSC2 RASGRF1 DOCK9 GRIN2B ARHGAP39 PACS1 LLGL1 FAM171A2 ENAH CD44 FAM169A MACF1 ADGRE5 PEAK1	4.53e-05	1063	310	34	int:RAC1
Interaction	PPIA interactions	ZHX3 STAM2 ILF3 ZNF148 SALL3 ZFYVE16 NACA PFKM BLM JAK2 SAFB AP2B1 AHNAK PKM TLN2 RPRD2 TACC1 ANK3 NTRK1 POU5F1 DNAJC2 EEF1B2 AFAP1 NECAP2 LLGL1 ARID2 CD44 MACF1 MPHOSPH8 HCFC1	4.88e-05	888	310	30	int:PPIA
Interaction	ABL1 interactions	ERBB4 ILF3 JAK2 EPS15L1 AP2B1 RAD51 BIN1 NTRK1 LARS1 PSTPIP1 SLC9A2 ENAH NFAT5 MUC1	5.20e-05	259	310	14	int:ABL1
Interaction	NUPR1 interactions	ILF3 NACA ITPRID2 RUVBL2 SAFB AP2A2 AP2B1 AHNAK PPP1R9B IMMT FLNA RANBP2 NUP214 PRPF40A KAT7 PPP1R8 TGM2 AFAP1 TJP1 MDC1 CD44 NUP133 SAFB2 MACF1 NUP188	6.06e-05	683	310	25	int:NUPR1
Interaction	AP2B1 interactions	CCP110 GAK EPS15L1 ALMS1 AP2A2 AP2B1 SNAP91 ATXN1 PPP1R9B HEATR5B FLNA SLC2A8 NTRK1 LARS1 NECAP2 N4BP2 CEP152	7.21e-05	373	310	17	int:AP2B1
Interaction	CSNK2A1 interactions	IL16 ILF3 NACA RUVBL2 PGR SAFB PTPRC F11R ATXN1 RPRD2 RAD51 JADE2 ZCCHC8 NTRK1 FNBP4 POU5F1 GRIN2B APOE ADNP PRPF40A KAT7 PPP1R8 PACS1 EEF1B2 MDC1 NUP133 ANKRD11 MACF1 SNAPC4 HCFC1 KIF1C	7.77e-05	956	310	31	int:CSNK2A1
Interaction	NLK interactions	CCP110 ZHX3 DCAF6 PASK ATXN1 PKM RANBP2	9.96e-05	70	310	7	int:NLK
Interaction	KCTD13 interactions	IL16 GAK ILF3 MYO9A ANKS1B PFKM PLD3 PFKP EPS15L1 AP2A2 AP2B1 SNAP91 PTPRS PKM PKP2 TLN2 PPP1R9B PRRC2A IMMT CNTN2 FLNA BIN1 ANK3 PRR36 WDR7 LARS1 YTHDC2 GRIN2B ARHGAP39 APOE PRPF40A KAT7 PACS1 EEF1B2 AFAP1 TJP1 VCAN TLN1 MACF1 PEAK1	1.04e-04	1394	310	40	int:KCTD13
Interaction	PRC1 interactions	ILF3 NACA PFKM RUVBL2 SAFB AP2A2 AHNAK PKP2 COBL IMMT PHIP FOXM1 FLNA RANBP2 PRPF40A NCOA5 KAT7 ZNF750 AFAP1 CELSR3 TJP1 MDC1 NUP133 SAFB2 CNTNAP4 NUP188 SNAPC4 PATJ CDC25A AQR SON	1.07e-04	973	310	31	int:PRC1
Interaction	PML interactions	SP2 ILF3 ZNF148 GMEB2 BLM EPS15L1 SAFB ATXN1 AHNAK SYNE2 PKM PKP2 OXSR1 PHIP RAD51 FOXM1 FLNA RANBP2 VPS37A NTRK1 POU5F1 PRPF40A RBM12 PELP1 TJP1 ZBTB25 ATF7IP TLN1 MDC1 HCFC1	1.18e-04	933	310	30	int:PML
Interaction	SIRT6 interactions	ILF3 RUVBL2 FANCA BLM PKP2 RPRD2 FLNA RANBP2 FAT3 FNBP4 YTHDC2 ZDBF2 POU5F1 NUP214 ADNP CELSR3 PELP1 ARID2 MDC1 NUP133 ANKRD17 NUP188 AQR	1.19e-04	628	310	23	int:SIRT6
Interaction	PIP5KL1 interactions	PIP5KL1 PIP5K1A PIP5K1B	1.21e-04	7	310	3	int:PIP5KL1
Interaction	RPS6KL1 interactions	RPRD2 RANBP2 NUP214 NUP133 NUP188 SON	1.27e-04	51	310	6	int:RPS6KL1
Interaction	FGFR1 interactions	STAM2 ZFYVE16 PFKP RUVBL2 JAK2 AP2B1 SNAP91 PKM PKP2 TACC1 MERTK IMMT ANK3 NTRK1 MST1R MRPS7 PACS1 AFAP1 NECAP2 FAM171A2 CD44 NUP188 PEAK1	1.30e-04	632	310	23	int:FGFR1
Interaction	ZSCAN31 interactions	PNPT1 PIP5K1A NOL8 YTHDC2	1.42e-04	18	310	4	int:ZSCAN31
Interaction	FBXW11 interactions	HIVEP1 ILF3 NACA MAST2 NFE2L1 COBL TACC1 MERTK PRRC2A FLNA RANBP2 PHTF2 YTHDC2 REST LLGL1 CDC25A HCFC1 SON BORA	1.45e-04	473	310	19	int:FBXW11
Interaction	PKD1 interactions	NPHP4 JAK2 PTPRS PKD1 ATF7IP TLN1	1.58e-04	53	310	6	int:PKD1
Interaction	VHL interactions	GAK ILF3 PFKP MAP3K1 FBXL4 FANCA JAK2 PKP2 FBXO34 FLNA WDR7 TGM2 EEF1B2 ZNF827 ATF7IP ARID2 CD44 ANKRD11 PRKG1 EPAS1 SON	1.74e-04	561	310	21	int:VHL
Interaction	SYNE3 interactions	CCP110 GAK ITPRID2 ALMS1 SYNE2 MTMR3 PKP2 COL14A1 TACC1 RANBP2 NUP214 PRPF40A PALB2 CEP164 N4BP2 NUP133 MACF1 CEP152	1.94e-04	444	310	18	int:SYNE3
Interaction	AXL interactions	PFKM PLD3 EPS15L1 AHNAK MERTK IMMT FLNA NTRK1 WWP1 UBXN6 MRPS7 EVA1B LLGL1 TJP1 CD44 NUP188	2.07e-04	369	310	16	int:AXL
Interaction	AFDN interactions	F11R ATXN1 PKP2 SDK1 DSC2 NTRK1 POU5F1 ARHGAP39 LLGL1 FAM171A2 TJP1 MACF1 CEP152 PEAK1 PATJ	2.16e-04	333	310	15	int:AFDN
Interaction	BRCA1 interactions	HIVEP1 ILF3 ZNF148 NACA ITPRID2 PFKM PFKP RUVBL2 MAP3K1 PGR FANCA BLM JAK2 ALMS1 AP2B1 SNAP91 AHNAK PKM PPP1R9B USH2A RAD51 FLNA ZCCHC8 LARS1 FNBP4 NUP214 PALB2 TGM2 EEF1B2 AFAP1 ZNF827 TLN1 MDC1 NUP133 HCFC1 BORA	2.16e-04	1249	310	36	int:BRCA1
Interaction	ZBTB2 interactions	ILF3 GMEB2 SAFB SUCO IMMT PHIP AKIRIN2 POU5F1 PRPF40A NCOA5 KAT7 MRPS7 PELP1 ZBTB25 TLN1 MDC1 SAFB2 SON	2.28e-04	450	310	18	int:ZBTB2
Cytoband	2q33.3	CPO DYTN ZDBF2 EEF1B2	5.37e-05	30	318	4	2q33.3
GeneFamily	CD molecules\|Mucins	MUC17 MUC20 MUC19 MUC16 MUC1 MUC4	1.13e-07	21	212	6	648
GeneFamily	Fibronectin type III domain containing	IGSF22 PTPRC PTPRS COL14A1 MERTK USH2A SDK1 CNTN2 FSD2 ATF7IP CNTN3 IGSF9B	4.16e-07	160	212	12	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	IGSF22 HMCN2 PTPRS PXDNL ADGRF5 MERTK SDK1 CNTN2 HSPG2 CNTN3 IGSF9B CEACAM20	4.45e-07	161	212	12	593
GeneFamily	Immunoglobulin like domain containing	HMCN2 F11R VSIG10L ADGRF5 MERTK SDK1 CNTN2 HSPG2 NTRK1 ICAM2 CNTN3 IGSF9B CEACAM20	4.71e-07	193	212	13	594
GeneFamily	Nucleoporins	RANBP2 NUP214 NUP133 NUP188	5.11e-04	32	212	4	1051
GeneFamily	Cadherin related	FAT2 FAT3 DCHS1	9.57e-04	17	212	3	24
GeneFamily	MAGE family	MAGEA4 TRO MAGEC1 MAGEC2	1.21e-03	40	212	4	1136
GeneFamily	Peptidyl arginine deiminases	PADI1 PADI2	1.34e-03	5	212	2	677
GeneFamily	Ring finger proteins\|Fanconi anemia complementation groups\|Protein phosphatase 1 regulatory subunits\|BRCA1 A complex\|BRCA1 B complex\|BRCA1 C complex	FANCA RAD51 PALB2	1.56e-03	20	212	3	548
GeneFamily	Adhesion G protein-coupled receptors, subfamily G	ADGRG4 ADGRG2	2.76e-03	7	212	2	917
GeneFamily	Blood group antigens\|CD molecules\|Proteoglycans	HSPG2 CD44	2.76e-03	7	212	2	570
GeneFamily	Glutamate ionotropic receptor NMDA type subunits	GRIN2B GRIN2C	2.76e-03	7	212	2	1201
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ZHX3 HIVEP1 ZNF148 ZFYVE16 RABGAP1 PHF8 MAST2 BLM ATXN1 SYNE2 MTMR3 PIP5K1A ANKMY2 PLCB4 OXSR1 SUCO PHIP MED13 RANBP2 WDR7 WWP1 DOCK9 ADNP DNAJC2 AFAP1 FAM169A NUP133 ANKRD17 MACF1 BICRAL AQR SON	1.88e-08	856	317	32	M4500
Coexpression	LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS	TSC22D1 RBMS3 AHNAK PIP5K1B ADGRF5 TACC1 LAMA2 PHTF2 PIEZO2 TJP1 ANKRD11 PRKG1 EPAS1	2.69e-07	177	317	13	M39245
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	ZHX3 MAST2 KMT2C PKM MED13 KAT7 PELP1 ATF7IP TTLL4 TLN1 MACF1 NFAT5 HCFC1	3.27e-07	180	317	13	M8239
Coexpression	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	CCP110 STAM2 ZNF148 RABGAP1 KMT2C TSC22D1 FAT2 F11R ATXN1 NFE2L1 AHNAK SYNE2 PKM PKP2 PIP5K1A AMOTL2 DSC2 AKIRIN2 C8orf58 DNAJC2 TGM2 WASH3P TJP1 ARID2 TLN1 MDC1 ENAH CD44 AP4B1	5.07e-07	843	317	29	M2356
Coexpression	GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN	HIVEP1 MAP3K1 PTPRS PKM CACNA1I MERTK PHIP WWP1 PELI1 LRRC8D MACF1 IGSF9B NFAT5	5.71e-07	189	317	13	M3112
Coexpression	SMID_BREAST_CANCER_BASAL_UP	MAGEA4 EXTL1 PFKP FANCA FAT2 CCL8 PLCB4 DMRT1 MOCOS FOXM1 FLNA LRP12 PLAAT1 DSC2 MUC16 PELI1 POU5F1 ZNF750 ADGRG2 TTLL4 MDC1 CD44 CDC25A PADI2	2.07e-06	662	317	24	M8124
Coexpression	GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN	MAP3K1 ATXN1 SYNE2 PLA2G6 RPRD2 JADE2 DOCK9 TTYH2 FNBP4 LRRC8D ZBTB25 CD44	6.41e-06	200	317	12	M8620
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	GIMAP4 IL16 ZNF148 KMT2C PTPRC ATXN1 AHNAK TACC1 PHIP MED13 SELPLG FLNA RANBP2 BIN1 JADE2 DOCK9 FNBP4 PHTF2 YTHDC2 REST PSTPIP1 PRPF40A PACS1 EEF1B2 RBM12 ATF7IP ARID2 TLN1 CD44 ANKRD11 MACF1 ELF1 ADGRE5 MPHOSPH8 TRAF3IP3 AP4B1 NFAT5 SON	1.25e-05	1492	317	38	M40023
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	ZHX3 VWA8 ANKS1B SYNE2 TLN2 TACC1 SDK1 PRUNE2 ANK3 ANKRD11 SAFB2 PATJ	1.75e-05	221	317	12	M39222
Coexpression	AIZARANI_LIVER_C33_STELLATE_CELLS_2	TSC22D1 RBMS3 ADGRF5 FLNA ANK3 TLN1 ENAH PRKG1 EPAS1	2.36e-05	126	317	9	M39132
Coexpression	BENPORATH_SUZ12_TARGETS	ERBB4 CDX4 KLHL35 PGR HOXB8 HOXD13 KCNH1 LIPG PIP5K1B RIMBP3C SHISAL2A DMRT1 MGARP PCSK9 AFF2 RASGRF1 NTRK1 PCDH11Y GRIN2B KCNH3 RIMBP3 KCNV1 SLC9A2 GUCY2D CD44 ANKRD11 PRKG1 RIMBP3B EPAS1	2.64e-05	1035	317	29	M9898
Coexpression	GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP	PCYOX1L AHNAK PLA2G6 CACNA1I PLCB4 CAMTA1 KCNV1 WDR91 EEF1B2 CD40LG PRKG1	3.18e-05	198	317	11	M5584
Coexpression	GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP	R3HCC1L AHNAK TLN2 TMEM184B USH2A ZBTB25 VCAN TTLL4 DCHS1 MPHOSPH8 MFSD5	3.33e-05	199	317	11	M5233
Coexpression	GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN	MAGEA4 GAK PYROXD1 NPHP4 NFE2L1 ADGRF5 PRRC2A WDR7 JADE2 ANKRD17 PADI2	3.33e-05	199	317	11	M5251
Coexpression	GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP	RUVBL2 HOXB8 AP2B1 STRADA SCN9A PRRC2A GRIA4 EEF1B2 LLGL1 ADGRE5 CDC25A	3.48e-05	200	317	11	M9667
Coexpression	GSE30083_SP1_VS_SP4_THYMOCYTE_DN	TRAF3IP2 MANBA FAAH AHNAK SYNE2 RPRD2 SELPLG ZBTB25 CD44 ADGRE5 CTSE	3.48e-05	200	317	11	M5030
Coexpression	GSE3982_MAST_CELL_VS_TH2_DN	BLM PIP5K1B FOXM1 PCDH11Y CEP152 TRAF3IP3 NUP188 CDC25A NFAT5 EPAS1 BORA	3.48e-05	200	317	11	M5456
Coexpression	DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS	PASK FAT2 RBMS3 CACNA1I SDK1 ANK3 DSC2 ADGRG2 CNTN3 PRKG1 PATJ CDH4	4.63e-05	244	317	12	M40312
Coexpression	GABRIELY_MIR21_TARGETS	MYO9A RABGAP1 MAP3K1 SYNE2 TACC1 PHIP PELI1 YTHDC2 ADNP ADGRG2 ENAH CDC25A NFAT5	5.64e-05	289	317	13	M2196
Coexpression	AIGNER_ZEB1_TARGETS	F11R DSC2 PATJ MUC1 CDH4	6.04e-05	35	317	5	M14590
Coexpression	GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN	ZHX3 DCAF6 MYO9A ZDHHC8 TSC22D1 PLCB4 WWP1 FNBP4 TGM2 ARID2	6.92e-05	179	317	10	M6689
Coexpression	PASINI_SUZ12_TARGETS_UP	MANBA PFKP PNMA5 KMT2C COBL ENAH BICRAL EPAS1	7.14e-05	113	317	8	M2291
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	ILF3 RABGAP1 FANCA PIP5K1A PRRC2A NOL8 FNBP4 NUP214 WASH3P LLGL1 TLN1 SAFB2 SNAPC4 HCFC1	7.16e-05	338	317	14	M17094
Coexpression	LIM_MAMMARY_STEM_CELL_UP	TRO QRICH2 SVEP1 RUSC2 PKD1 COL14A1 TACC1 MGARP HSPG2 RARRES2 TTYH2 APOE VCAN DCHS1 MYOCD CDH4 EPAS1	8.45e-05	479	317	17	M2573
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	ANKS1B RUSC1 PFKP RUSC2 FAT2 F11R SNAP91 RBMS3 SCN9A TLN2 CACNA1I PLCB4 CAMTA1 LRP12 AFF2 ANK3 MUC19 GRIA4 PACS1 PIEZO2 CELSR3 N4BP2 VCAN PNMA2 FAM169A CNTNAP4 IGSF9B CDH4 HYDIN	8.56e-05	1106	317	29	M39071
Coexpression	LIM_MAMMARY_STEM_CELL_UP	TRO QRICH2 SVEP1 RUSC2 PKD1 COL14A1 TACC1 MGARP HSPG2 RARRES2 TTYH2 APOE VCAN DCHS1 MYOCD CDH4 EPAS1	9.34e-05	483	317	17	MM1082
Coexpression	CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP	ILF3 EXTL1 PFKM PLD3 BLM PASK PCYOX1L AP2B1 PKM PIP5K1B CACNA1I TACC1 SDK1 HSPG2 RASGRF1 FAM182B SLC45A4 LLGL1 CELSR3 FER1L4 VCAN ENAH CEP152 GREB1 BORA	9.42e-05	891	317	25	M45033
Coexpression	GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP	SP2 MYO9A NFE2L1 PPP1R9B MERTK HEATR5B PELI1 ARHGAP39 PADI2	9.72e-05	151	317	9	M6498
Coexpression	LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR	RBMS3 AHNAK ADGRF5 TACC1 PLCB4 DOCK9 TJP1 MACF1 EPAS1	1.02e-04	152	317	9	M39243
Coexpression	MARSON_BOUND_BY_FOXP3_UNSTIMULATED	TRAF3IP2 GIMAP4 HIVEP1 MANBA MAP3K1 BLM JAK2 SCNM1 PTPRC AP2A2 ATXN1 STRADA PKM ANKMY2 RANBP2 SLC2A8 ICAM2 PHTF2 REST CR1L LRRC8D PRPF40A TJP1 ZBTB25 ATF7IP ELF1 MPHOSPH8 PEAK1 ATP1A2 AP4B1 CTSE	1.14e-04	1239	317	31	M1743
Coexpression	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP	GIMAP4 JAK2 POU5F1 APOE PACS1	1.17e-04	40	317	5	M19976
Coexpression	DESCARTES_ORGANOGENESIS_ENDOTHELIAL_CELLS	GIMAP4 F11R ADGRF5 DOCK6 HSPG2 DOCK9 ICAM2 C8orf58 TJP1 ADGRE5 PEAK1 EPAS1	1.30e-04	272	317	12	MM3634
Coexpression	ZHENG_BOUND_BY_FOXP3	GIMAP4 MAP3K1 EPS15L1 PTPRC SYNE2 MUC20 LARS1 PHTF2 PELI1 CR1L ZBTB25 CD44 ANKRD11 MACF1 ELF1 TRAF3IP3 AQR	1.35e-04	498	317	17	M1741
Coexpression	GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN	TRO FAT2 KCNH1 CACNA1I USH2A FOXM1 FAM182B ZBTB25 SAFB2 IGSF9B	1.35e-04	194	317	10	M5767
Coexpression	BENPORATH_PRC2_TARGETS	ERBB4 KLHL35 PGR HOXB8 HOXD13 KCNH1 PIP5K1B RIMBP3C DMRT1 MGARP RASGRF1 NTRK1 KCNH3 RIMBP3 KCNV1 SLC9A2 GUCY2D PRKG1 RIMBP3B EPAS1	1.44e-04	650	317	20	M8448
Coexpression	PASINI_SUZ12_TARGETS_UP	MANBA PFKP PNMA5 KMT2C COBL ENAH BICRAL EPAS1	1.45e-04	125	317	8	MM1065
Coexpression	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	ILF3 PASK ALMS1 SYNE2 RAD51 FOXM1 JADE2 PHTF2 KAT7 TTLL4 ENAH MPHOSPH8 CEP152 PATJ CDC25A BORA	1.47e-04	454	317	16	M19927
Coexpression	GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP	MAGEA4 NACA TSC22D1 HOXB8 BIN1 WWP1 LARS1 ZBTB25 CD44 MACF1	1.59e-04	198	317	10	M5591
Coexpression	GSE3982_MAC_VS_NKCELL_DN	CYP2C9 RUSC1 ZBP1 SYNE2 ANK3 JADE2 ADGRE5 IGSF9B TRAF3IP3 HCFC1	1.59e-04	198	317	10	M5509
Coexpression	GSE23695_CD57_POS_VS_NEG_NK_CELL_UP	POLR3H ANKHD1 EPS15L1 TELO2 RANBP2 DNAJC2 LLGL1 PELP1 MFSD5 AQR	1.66e-04	199	317	10	M7784
Coexpression	GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP	NACA TSC22D1 PTPRC ALMS1 WWP1 CD44 MACF1 ELF1 MPHOSPH8 SON	1.66e-04	199	317	10	M7596
Coexpression	ZHENG_BOUND_BY_FOXP3	GIMAP4 MAP3K1 EPS15L1 PTPRC SYNE2 MUC20 LARS1 PHTF2 PELI1 CR1L ZBTB25 CD44 ANKRD11 MACF1 ELF1 TRAF3IP3 AQR	1.67e-04	507	317	17	MM1030
Coexpression	GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP	GIMAP4 HIVEP1 ZFYVE16 FBXL4 PASK PTPRC ALMS1 PRPF40A ATF7IP CD40LG	1.73e-04	200	317	10	M8030
Coexpression	GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN	ITPRID2 PFKP JAK2 NFE2L1 LIPG VSIG10L NOL8 PELI1 POU5F1 CDC25A	1.73e-04	200	317	10	M6095
Coexpression	GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP	ZHX3 RASGRF1 PRR36 DOCK9 REST NUBPL LRRC8D WDR91 IGSF9B PATJ	1.73e-04	200	317	10	M8975
Coexpression	GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN	GAK ILF3 RUSC1 PFKP SAFB TELO2 SCN9A RANBP2 EEF1B2 PADI2	1.73e-04	200	317	10	M5234
Coexpression	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP	GIMAP4 JAK2 POU5F1 APOE PACS1	1.85e-04	44	317	5	MM806
Coexpression	MARSON_BOUND_BY_FOXP3_UNSTIMULATED	TRAF3IP2 GIMAP4 HIVEP1 MANBA MAP3K1 BLM JAK2 SCNM1 PTPRC AP2A2 ATXN1 STRADA PKM ANKMY2 RANBP2 SLC2A8 ICAM2 PHTF2 REST CR1L LRRC8D PRPF40A TJP1 ZBTB25 ATF7IP ELF1 MPHOSPH8 PEAK1 ATP1A2 AP4B1 CTSE	1.94e-04	1277	317	31	MM1032
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	ZFYVE16 EPS15L1 PLA2G6 TTLL4 MACF1 SNAPC4 NFAT5 CPEB1 SON	1.99e-04	166	317	9	M6826
Coexpression	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	ERBB4 PFKP AHNAK FOXM1 LRP12 PLAAT1 DSC2 WWP1 PELI1 LRRC8D TTLL4 CD44 GREB1	2.05e-04	329	317	13	M5652
Coexpression	PUJANA_BREAST_CANCER_LIT_INT_NETWORK	FANCA BLM JAK2 RAD51 FLNA MDC1 CDC25A	2.31e-04	101	317	7	M15356
Coexpression	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON	SP2 HSF5 HOXB8 NFE2L1 STRADA PPP1R9B MED13 ICAM2 TTYH2 GRIN2C KAT7 MRPS7 ZNF750	2.37e-04	334	317	13	M15936
Coexpression	RUBENSTEIN_SKELETAL_MUSCLE_ENDOTHELIAL_CELLS	GIMAP4 AHNAK SYNE2 ADGRF5 TACC1 HSPG2 ICAM2 EPAS1	2.72e-04	137	317	8	M41743
Coexpression	LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES	RBMS3 ADGRF5 TACC1 TJP1 MACF1 PRKG1 PEAK1 EPAS1	2.72e-04	137	317	8	M39241
Coexpression	DESCARTES_FETAL_CEREBELLUM_GRANULE_NEURONS	HMCN2 PCSK9 DYTN MUC19 GRIN2C	2.80e-04	48	317	5	M40165
Coexpression	CAIRO_HEPATOBLASTOMA_CLASSES_DN	AADAC CYP2C9 SVEP1 TSC22D1 AMOTL2 RARRES2 RASGRF1 JADE2 LAMA2 TJP1	2.87e-04	213	317	10	M12176
Coexpression	ZHONG_PFC_C3_ASTROCYTE	PFKP KIAA0319 SNAP91 PTPRS PKD1 SCN9A BIN1 ANK3 ARHGAP39 CEP164 PACS1 AFAP1 CNTN3 SNAPC4	3.07e-04	389	317	14	M39102
Coexpression	SMID_BREAST_CANCER_LUMINAL_B_DN	EXTL1 PFKP SVEP1 PTPRC COL14A1 ADGRF5 FLNA BIN1 PLAAT1 DSC2 ICAM2 MUC16 PELI1 ADGRG2 VCAN TTLL4 TRAF3IP3 PADI2	3.20e-04	587	317	18	M17572
Coexpression	CUI_TCF21_TARGETS_2_DN	GIMAP4 SP2 HIVEP1 ZFYVE16 ITPRID2 KMT2C PTPRC AHNAK ADGRF5 TACC1 MERTK HEATR5B MED13 VPS37A FAM13C ICAM2 C8orf58 MACF1 ELF1 ADGRE5 PRKG1 EPAS1 SON	3.21e-04	854	317	23	M1533
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500	ZHX3 ILF3 RABGAP1 SMOC1 IMMT MED13 ANK3 FAT3 NUP214 VCAN MYOCD NFAT5	2.47e-06	149	316	12	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5
CoexpressionAtlas	dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000	TRAF3IP2 HIVEP1 MANBA MYO9A PHF8 SMOC1 MAST2 TSC22D1 F11R KCNH1 LIPG PKP2 PPP1R9B TACC1 MERTK DMRT1 SUCO AFF2 DSC2 FAT3 DOCK9 PELI1 ARHGAP39 LRRC8D TMX2 ZNF827 N4BP2 VCAN FAM169A ATP1A2 PATJ	3.19e-06	837	316	31	gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000	ILF3 MANBA VWA8 RABGAP1 FAAH FANCA HOXB8 AP2A2 PKP2 SUCO IMMT MED13 MUC20 ANK3 DSC2 SLC2A8 PRR36 PELI1 NUP214 CEP164 ARID2 VCAN PATJ NFAT5 MUC1 CTSE PADI2 CDH4	1.98e-05	786	316	28	gudmap_developingKidney_e15.5_Medullary collecting duct_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500	ZHX3 ILF3 RABGAP1 SMOC1 TLN2 PHIP MED13 ANK3 FAT3 VCAN MYOCD PRKG1	3.60e-05	194	316	12	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000	ILF3 VWA8 RABGAP1 AP2A2 SUCO IMMT MED13 ANK3 PELI1 NUP214 CEP164 ARID2 VCAN NFAT5	3.99e-05	261	316	14	gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000	SVEP1 RTL3 ATXN1 COL14A1 FAT3 APOE TGM2 ADGRG2 TLN1 MYOCD PRKG1 ATP1A2	4.18e-05	197	316	12	gudmap_developingGonad_e16.5_epididymis_1000_k5
CoexpressionAtlas	kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000	IL16 SVEP1 PTPRC F11R AHNAK SYNE2 COBL COL14A1 C4B CCL8 RARRES2 LAMA2 MUC16 GRIA4 APOE TMEM108 CPEB1	4.24e-05	369	316	17	gudmap_kidney_adult_RenalCapsule_k2_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	TRAF3IP2 ERBB4 PHF8 SMOC1 SVEP1 SYCE2 PTPRS KCNH1 COL14A1 MERTK FOXM1 FLNA AFF2 RARRES2 DSC2 FAT3 LAMA2 MUC16 GRIA4 ZDBF2 REST TGM2 VCAN MDC1 MYOCD TMEM108 PRKG1	6.05e-05	793	316	27	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5	SVEP1 TSC22D1 F11R RBMS3 COL14A1 C4A C4B AMOTL2 HSPG2 RARRES2 DSC2 NTRK1 LAMA2 APOE TGM2 PIEZO2 DCHS1 ATP1A2 EPAS1	7.87e-05	466	316	19	GSM777050_500
CoexpressionAtlas	dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_500	GIMAP4 SMOC1 PTPRC LIPG ADGRF5 PLCB4 DOCK6 MGARP HSPG2 AFF2 FAM13C FAT3 ICAM2 APOE PIEZO2 TJP1 ADGRE5 EPAS1	8.71e-05	430	316	18	gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	DCAF6 ZNF148 SVEP1 KMT2C RTL3 ATXN1 RBMS3 SYNE2 PIP5K1A COL14A1 IMMT FAT3 FNBP4 PELI1 REST APOE KCNH3 KAT7 TGM2 ADGRG2 TLN1 ANKRD11 MYOCD PRKG1 ATP1A2 NFAT5	1.43e-04	790	316	26	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000	ERBB4 MANBA PHF8 SMOC1 PLD3 MAST2 MAP3K1 KCNH1 LIPG SYNE2 PKP2 PIP5K1B COL14A1 PPP1R9B TACC1 MERTK DMRT1 AFF2 DSC2 TTYH2 ZDBF2 ARHGAP39 SLC45A4 TMX2 SLC9A2 VCAN ATP1A2 PADI2	1.51e-04	884	316	28	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000	GIMAP4 ZHX3 ILF3 VWA8 PFKP HOXB8 MTMR3 COL14A1 SUCO MED13 ANK3 RASGRF1 FNBP4 PELI1 NUP214 LRRC8D PRPF40A ARID2 ENAH CNTN3 MYOCD GREB1 PATJ NFAT5 MUC1 CDH4	1.58e-04	795	316	26	gudmap_developingKidney_e15.5_anlage of loop of Henle_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	DCAF6 ZNF148 MYO9A PLD3 HSF5 MAP3K1 ENO4 KMT2C SNAP91 SYNE2 PIP5K1A CAMTA1 IMMT TTYH2 FNBP4 PHTF2 YTHDC2 ADGRG2 CD44 ANKRD11 ANKRD17 GREB1 PEAK1 NFAT5 CTSE CPEB1	1.58e-04	795	316	26	gudmap_developingGonad_e16.5_ovary_1000
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	ERBB4 ANKS1B TSC22D1 HMCN2 COL14A1 PLCB4 SDK1 PRUNE2 FLNA FAT3 ENAH MACF1 ADGRE5 MYOCD PRKG1	7.34e-12	188	318	15	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	ANKS1B TSC22D1 HMCN2 COL14A1 PLCB4 SDK1 PRUNE2 FLNA FAT3 ENAH MACF1 ADGRE5 MYOCD PRKG1	1.00e-10	189	318	14	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BEST3 ITPRID2 SMOC1 PFKP KCNH1 SYNE2 SCN9A ADGRF5 PLCB4 MUC20 RARRES2 FAT3 SLC9A2	8.42e-10	184	318	13	a60802e11dcc5f932811260b08a95a32f60f6b19
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BEST3 ITPRID2 SMOC1 PFKP KCNH1 SYNE2 SCN9A ADGRF5 PLCB4 MUC20 RARRES2 FAT3 SLC9A2	8.42e-10	184	318	13	2a2fb691cc9414ef5b06c26239d2da03d6d7e5c2
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BEST3 ITPRID2 SMOC1 PFKP KCNH1 SYNE2 SCN9A ADGRF5 PLCB4 MUC20 RARRES2 FAT3 SLC9A2	8.42e-10	184	318	13	39c230d32e4259bc784e0edfd9e2884c96898564
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	SVEP1 TSC22D1 PTPRS COL14A1 TACC1 FLNA RARRES2 LAMA2 AFAP1 VCAN PNMA2 MACF1 PEAK1	1.17e-09	189	318	13	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SVEP1 USH2A FAT3 MUC19 LAMA2 GRIA4 GRIN2B CNTNAP4 CNTN3 MYOCD HYDIN SPESP1	1.91e-09	160	318	12	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SVEP1 USH2A FAT3 MUC19 LAMA2 GRIA4 GRIN2B CNTNAP4 CNTN3 MYOCD HYDIN SPESP1	1.91e-09	160	318	12	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PGR HMCN2 COL14A1 PLCB4 PRUNE2 FLNA FAM13C FAT3 ENAH MYOCD IGSF9B PRKG1 ATP1A2	1.94e-09	197	318	13	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	IL16 SVEP1 PTPRS COL14A1 SDK1 RARRES2 FAT3 LAMA2 PIEZO2 VCAN ENAH TMEM108 PRKG1	2.06e-09	198	318	13	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANKS1B PXDNL COL14A1 TLN2 PLCB4 PRUNE2 FAM13C FAT3 MYOCD IGSF9B PRKG1 ATP1A2	4.66e-09	173	318	12	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	PXDNL COL14A1 TLN2 PRUNE2 FLNA FAM13C FAT3 VCAN MYOCD IGSF9B PRKG1 ATP1A2	7.28e-09	180	318	12	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	ANKS1B HMCN2 PIP5K1B COL14A1 PLCB4 SDK1 PRUNE2 FLNA FAT3 ADGRE5 MYOCD PRKG1	8.77e-09	183	318	12	818fd886e0188091310825f9145fa53328f2c979
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	RBMS3 COL14A1 PLCB4 SDK1 PRUNE2 FAM13C LAMA2 VCAN ENAH MYOCD PRKG1 ATP1A2	1.12e-08	187	318	12	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	COVID-19-Epithelial-Ionocytes\|COVID-19 / Condition, Lineage and Cell class	ADGRF5 C4B PLCB4 MUC20 HSPG2 RARRES2 PRR36 MUC16 ZNF750 SLC9A2 TJP1 MUC1	1.19e-08	188	318	12	a581cb9528d0febbf3addbb4f6bc140f91a584e6
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ERBB4 BEST3 BLM RBMS3 SCN9A PIP5K1B SDK1 AFF2 SLC9A2 AFAP1 TMEM108 GREB1	1.34e-08	190	318	12	26843ec1d19ac85a50990705353b802745d33e4d
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SVEP1 RTL3 RBMS3 COL14A1 C4B CCL8 HSPG2 RARRES2 NTRK1 LAMA2 ATP1A2 CPEB1	1.50e-08	192	318	12	c3707243c5590d852c9f28429c96f50a1fa6b0dc
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	IL16 SVEP1 RBMS3 PTPRS SDK1 FAT3 LAMA2 PIEZO2 MACF1 TMEM108 PRKG1 CDH4	1.59e-08	193	318	12	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 PXDNL COL14A1 SDK1 RARRES2 FAT3 APOE PIEZO2 AFAP1 ENAH TMEM108 PRKG1	1.68e-08	194	318	12	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 PTPRS PXDNL COL14A1 SDK1 RARRES2 FAT3 APOE PIEZO2 AFAP1 TMEM108 PRKG1	1.68e-08	194	318	12	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	KMT2C PTPRC LIPG SYNE2 RANBP2 ANK3 DOCK9 FAM106C ATF7IP MACF1 ADGRE5	1.73e-08	156	318	11	1545169694f686d28648a68b552c2ae606599d66
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	ERBB4 SAXO2 SYNE2 COBL ADGRF5 PLCB4 SDK1 ANK3 ENAH DNAAF1 MUC4 HYDIN	1.78e-08	195	318	12	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	ERBB4 SAXO2 SYNE2 COBL ADGRF5 PLCB4 SDK1 ANK3 ENAH DNAAF1 MUC4 HYDIN	1.78e-08	195	318	12	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SVEP1 COL14A1 RARRES2 FAT3 LAMA2 PIEZO2 VCAN ENAH MACF1 TMEM108 PRKG1 CDH4	1.78e-08	195	318	12	1cdf5f296029ae424d9dba42e86a6d111e4896e6
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IL16 SVEP1 RBMS3 PTPRS SDK1 RARRES2 FAT3 LAMA2 PIEZO2 MACF1 TMEM108 PRKG1	1.89e-08	196	318	12	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A TSC22D1 SYNE2 PKM COBL SDK1 PRUNE2 ANK3 SLC45A4 CD44 PATJ HYDIN	2.00e-08	197	318	12	7e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SVEP1 COL14A1 FAT3 LAMA2 PIEZO2 VCAN ENAH CNTN3 MACF1 TMEM108 PRKG1 CDH4	2.00e-08	197	318	12	11a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ERBB4 BEST3 EXTL1 SMOC1 SNAP91 COBL PLAAT1 RARRES2 DOCK9 GRIN2B VCAN XKR5	2.11e-08	198	318	12	02d0d8a212e09c0962ab1dae6a885d26d357f66a
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IL16 SVEP1 RBMS3 PTPRS SDK1 RARRES2 FAT3 LAMA2 PIEZO2 ENAH MACF1 PRKG1	2.11e-08	198	318	12	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	GIMAP4 ITPRID2 KMT2C SYNE2 ADGRF5 PLCB4 DOCK6 DOCK9 TJP1 MACF1 EPAS1 SON	2.36e-08	200	318	12	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TSC22D1 FAT2 AHNAK SYNE2 MUC20 ANK3 MUC16 TJP1 ENAH MUC1 MUC4 EPAS1	2.36e-08	200	318	12	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZHX3 MYO9A AHNAK COL14A1 RANBP2 AFF2 APOE ATF7IP MACF1 MYOCD ATP1A2	6.01e-08	176	318	11	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HIVEP1 SNAP91 C4A CCL8 SDK1 TMEM200C RARRES2 TTYH2 CR1L PNMA2 PRKG1	6.37e-08	177	318	11	ac90e4ce5be304a5a7473736397327010f2d1999
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 PXDNL COL14A1 SDK1 TMPRSS9 FAT3 APOE PIEZO2 AFAP1 ENAH TMEM108	7.56e-08	180	318	11	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 PXDNL COL14A1 SDK1 TMPRSS9 FAT3 APOE PIEZO2 AFAP1 ENAH TMEM108	7.56e-08	180	318	11	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	ANKS1B HMCN2 COL14A1 SDK1 PRUNE2 FLNA FAT3 ENAH ADGRE5 MYOCD PRKG1	8.95e-08	183	318	11	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCN9A TLN2 USH2A SDK1 CNTN2 FAT3 GRIN2B PIEZO2 CNTNAP4 MYOCD HYDIN	9.46e-08	184	318	11	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCN9A TLN2 USH2A SDK1 CNTN2 FAT3 GRIN2B PIEZO2 CNTNAP4 MYOCD HYDIN	9.46e-08	184	318	11	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCN9A TLN2 USH2A SDK1 CNTN2 FAT3 GRIN2B PIEZO2 CNTNAP4 MYOCD HYDIN	9.46e-08	184	318	11	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	IL16 SVEP1 RBMS3 PTPRS SDK1 FAT3 LAMA2 PIEZO2 MACF1 TMEM108 PRKG1	1.11e-07	187	318	11	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	KMT2C PTPRC SYNE2 SUCO MED13 RANBP2 ATF7IP ARID2 ANKRD11 MACF1 NFAT5	1.18e-07	188	318	11	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ERBB4 BLM RBMS3 PXDNL SCN9A PIP5K1B SDK1 AFF2 AFAP1 TMEM108 GREB1	1.24e-07	189	318	11	78cf414b98bcb19deb934409acddaad1cd51b67f
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 PTPRS PXDNL COL14A1 SDK1 RARRES2 FAT3 APOE PIEZO2 TMEM108 PRKG1	1.24e-07	189	318	11	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ERBB4 BEST3 BLM RBMS3 SCN9A SDK1 AFF2 EYS AFAP1 GREB1 PRKG1	1.31e-07	190	318	11	3f22c118d552345f731d4d49f0bcb5765d93de3b
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 PXDNL COL14A1 SDK1 RARRES2 FAT3 APOE PIEZO2 AFAP1 VCAN PRKG1	1.38e-07	191	318	11	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IL16 SVEP1 RBMS3 PTPRS SDK1 FAT3 LAMA2 PIEZO2 MACF1 TMEM108 PRKG1	1.38e-07	191	318	11	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SVEP1 RBMS3 COL14A1 C4B CCL8 HSPG2 RARRES2 NTRK1 LAMA2 ATP1A2 CPEB1	1.46e-07	192	318	11	f9fb24457999dc9e751a099d7f995543b9330ad4
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 PXDNL COL14A1 SDK1 RARRES2 FAT3 APOE PIEZO2 AFAP1 TMEM108 PRKG1	1.46e-07	192	318	11	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	ERBB4 RBMS3 COBL ADGRF5 ANK3 TJP1 ENAH TMEM108 PATJ CTSE MUC4	1.46e-07	192	318	11	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IL16 SVEP1 RBMS3 PTPRS SDK1 FAT3 LAMA2 PIEZO2 MACF1 TMEM108 PRKG1	1.46e-07	192	318	11	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 PXDNL COL14A1 SDK1 RARRES2 FAT3 APOE PIEZO2 AFAP1 TMEM108 PRKG1	1.46e-07	192	318	11	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	IL16 SVEP1 RBMS3 PTPRS SDK1 FAT3 LAMA2 PIEZO2 MACF1 TMEM108 PRKG1	1.53e-07	193	318	11	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 PXDNL COL14A1 SDK1 RARRES2 FAT3 APOE PIEZO2 AFAP1 TMEM108 PRKG1	1.53e-07	193	318	11	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAT2 TLN2 PRUNE2 FAM13C LAMA2 ENAH CNTN3 MYOCD PRKG1 ATP1A2	1.59e-07	153	318	10	1524557514668f515ac1bbe847611f564b265b42
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	IL16 SVEP1 RBMS3 PTPRS TLN2 SDK1 FAT3 LAMA2 PIEZO2 TMEM108 PRKG1	1.62e-07	194	318	11	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 PTPRS PXDNL COL14A1 SDK1 RARRES2 FAT3 APOE PIEZO2 AFAP1 PRKG1	1.62e-07	194	318	11	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NACA ANKS1B SVEP1 RARRES2 LAMA2 PIEZO2 VCAN ENAH CNTNAP4 TMEM108 PRKG1	1.62e-07	194	318	11	28c5482da199bcee9e85258a88af453d9fdbd56a
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SVEP1 SDK1 FAT3 LAMA2 TGM2 PIEZO2 VCAN ENAH CNTN3 TMEM108 PRKG1	1.62e-07	194	318	11	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	PND01-03-samps-Mesenchymal\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	SVEP1 RBMS3 PTPRS TACC1 RARRES2 APOE ENAH PNMA2 MACF1 PEAK1 ATP1A2	1.62e-07	194	318	11	4f9bd0ded0dde1df885850714f29e73e992539a5
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	SVEP1 RBMS3 PTPRS SDK1 FAT3 LAMA2 TGM2 PIEZO2 ENAH TMEM108 PRKG1	1.70e-07	195	318	11	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PGR JAK2 HMCN2 COL14A1 FLNA FAT3 LAMA2 ENAH MYOCD PRKG1 ATP1A2	1.79e-07	196	318	11	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SVEP1 COL14A1 RARRES2 FAT3 LAMA2 PIEZO2 VCAN ENAH MACF1 TMEM108 PRKG1	1.79e-07	196	318	11	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	IL16 SVEP1 RBMS3 PTPRS COL14A1 TLN2 SDK1 FAT3 LAMA2 PIEZO2 PRKG1	1.79e-07	196	318	11	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PGR JAK2 HMCN2 COL14A1 FLNA FAT3 LAMA2 ENAH MYOCD PRKG1 ATP1A2	1.79e-07	196	318	11	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	SAXO2 SYNE2 COBL ADGRF5 PLCB4 SDK1 ANK3 ENAH MACF1 MUC4 HYDIN	1.79e-07	196	318	11	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	SAXO2 SYNE2 COBL ADGRF5 PLCB4 SDK1 ANK3 ENAH MACF1 MUC4 HYDIN	1.79e-07	196	318	11	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL14A1 RARRES2 FAT3 LAMA2 PIEZO2 VCAN ENAH MACF1 TMEM108 PRKG1 CDH4	1.89e-07	197	318	11	31a1852911bda38543916585fda34255fd62a134
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	SVEP1 RBMS3 COL14A1 SDK1 LAMA2 PIEZO2 AFAP1 VCAN ENAH TMEM108 PRKG1	1.89e-07	197	318	11	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SVEP1 COL14A1 FAT3 LAMA2 PIEZO2 VCAN ENAH CNTN3 MACF1 TMEM108 PRKG1	1.89e-07	197	318	11	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	AHNAK PRRC2A PHIP NOL8 PRPF40A CEP164 DNAJC2 PELP1 SAFB2 MPHOSPH8 CEP152	1.89e-07	197	318	11	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SVEP1 COL14A1 RARRES2 FAT3 LAMA2 PIEZO2 VCAN ENAH MACF1 TMEM108 PRKG1	1.99e-07	198	318	11	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	BLOOD\|World / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	GIMAP4 IL16 NACA PTPRC PKM SELPLG FLNA BIN1 NUP214 VCAN TRAF3IP3	2.09e-07	199	318	11	c2816a840ec3862d22e5efa8f0cdd0208635002d
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	SVEP1 PXDNL COL14A1 TMPRSS9 RARRES2 APOE TGM2 AFAP1 VCAN ENAH MACF1	2.09e-07	199	318	11	c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SVEP1 PXDNL COL14A1 RARRES2 TTYH2 APOE TGM2 AFAP1 VCAN MACF1 PRKG1	2.09e-07	199	318	11	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SVEP1 PXDNL COL14A1 RARRES2 APOE TGM2 AFAP1 VCAN MACF1 PRKG1 PEAK1	2.09e-07	199	318	11	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SVEP1 PGR PKP2 COL14A1 C4B RARRES2 PCDH11Y LAMA2 GRIA4 TMEM108 PRKG1	2.09e-07	199	318	11	0cdbedf09ec72734b86ddab3fec562e066afed92
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	SVEP1 PXDNL COL14A1 TMPRSS9 RARRES2 APOE TGM2 AFAP1 VCAN ENAH MACF1	2.20e-07	200	318	11	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 SVEP1 RBMS3 PTPRS COL14A1 SDK1 FAT3 LAMA2 PIEZO2 VCAN PRKG1	2.20e-07	200	318	11	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	GIMAP4 ITPRID2 AHNAK SYNE2 ADGRF5 PLCB4 DOCK6 DOCK9 TJP1 MACF1 EPAS1	2.20e-07	200	318	11	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Artery\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	GIMAP4 RABGAP1 ITPRID2 SYNE2 TACC1 PLCB4 MERTK DOCK6 DOCK9 CNTNAP4 EPAS1	2.20e-07	200	318	11	b1ff8d61b567f85006d6d20093f9c803b6d34674
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	GIMAP4 ITPRID2 SYNE2 ADGRF5 PLCB4 DOCK6 DOCK9 TGM2 TJP1 MACF1 EPAS1	2.20e-07	200	318	11	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	GIMAP4 ITPRID2 AHNAK SYNE2 ADGRF5 PLCB4 DOCK6 DOCK9 TJP1 MACF1 EPAS1	2.20e-07	200	318	11	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FAT2 F11R AHNAK SYNE2 MUC20 ANK3 TJP1 ENAH MUC1 MUC4 EPAS1	2.20e-07	200	318	11	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HMCN2 COL14A1 PLCB4 PRUNE2 FLNA FAM13C FAT3 MYOCD IGSF9B PRKG1 ATP1A2	2.20e-07	200	318	11	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	GIMAP4 ITPRID2 SYNE2 ADGRF5 PLCB4 DOCK6 DOCK9 TGM2 TJP1 MACF1 EPAS1	2.20e-07	200	318	11	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 ADGRG4 SVEP1 PGR RBMS3 COL14A1 TACC1 RARRES2 LAMA2 TGM2 VCAN	2.20e-07	200	318	11	3dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	ILF3 KMT2C AHNAK SYNE2 TACC1 FLNA TLN1 ANKRD11 MACF1 ELF1 SON	2.20e-07	200	318	11	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	SVEP1 PXDNL COL14A1 TMPRSS9 RARRES2 APOE TGM2 AFAP1 VCAN ENAH MACF1	2.20e-07	200	318	11	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PGR RBMS3 PIP5K1B LAMA2 PHTF2 PIEZO2 CNTN3 PRKG1 ATP1A2 EPAS1	2.28e-07	159	318	10	5ca96db4281abb5f646150ccf36adc66ab201c78
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EXTL1 SYNE2 COL14A1 C4B SHISAL2A RARRES2 MUC16 GRIN2C TGM2 TMEM108	3.59e-07	167	318	10	7abc785e688a384672d7fb5a62d32538fe7e5a51
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EXTL1 SYNE2 COL14A1 C4B SHISAL2A RARRES2 MUC16 GRIN2C TGM2 TMEM108	3.59e-07	167	318	10	d50311b1f66f143bae4c4cf50e2e9b13c85d6920
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	RBMS3 COBL ADGRF5 TACC1 ANK3 KCNV1 TJP1 PRKG1 PATJ EPAS1	4.23e-07	170	318	10	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PGR RBMS3 PIP5K1B LAMA2 PHTF2 PIEZO2 CNTN3 PRKG1 ATP1A2 EPAS1	4.23e-07	170	318	10	876b84740e15399bfff2b9c7f0b80fd759bbdb3f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PGR RBMS3 PIP5K1B LAMA2 PHTF2 PIEZO2 CNTN3 PRKG1 ATP1A2 EPAS1	4.23e-07	170	318	10	1f8738acf439d893880db7e1fdc9b3615ca00c39
ToppCell	Bronchial_Biopsy-Epithelial-Ionocytes\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	BEST3 SMOC1 SNAP91 KCNH1 SCN9A ADGRF5 RARRES2 FAT3 SLC9A2 ADGRG2	5.24e-07	174	318	10	7e7b13de916cd4fa0fa6fb06e6b4942877afa9fb
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZHX3 PGR RBMS3 TLN2 RARRES2 LAMA2 MACF1 PRKG1 PEAK1 ATP1A2	5.52e-07	175	318	10	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	Bronchial_Biopsy-Epithelial-Ionocytes\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	BEST3 SMOC1 SNAP91 KCNH1 SCN9A ADGRF5 RARRES2 FAT3 SLC9A2 ADGRG2	5.52e-07	175	318	10	13b8f7dc38c90b74d4a20a84a8705d8e2ec244f6
ToppCell	COVID-19-kidney-AQP1+SLC14A1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADGRF5 TACC1 PLCB4 DOCK6 HSPG2 DOCK9 PCDH11Y PELI1 SLC45A4 EPAS1	6.79e-07	179	318	10	1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba
ToppCell	frontal_cortex-Non-neuronal\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SALL3 F11R MERTK RARRES2 GRIN2C APOE EVA1B ATP1A2 EPAS1 SON	6.79e-07	179	318	10	ef01478bd03eb00f0ff2b6a8ae9244687c5f85aa
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 PXDNL COL14A1 SDK1 TMPRSS9 FAT3 APOE PIEZO2 AFAP1 TMEM108	7.52e-07	181	318	10	9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9
Drug	Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A	ILF3 RABGAP1 MAP3K1 JAK2 ALMS1 AP2A2 DSC2 PRR36 YTHDC2 ZNF750 AFAP1 CEP152 GREB1 NFAT5 HCFC1	6.70e-08	190	314	15	3373_DN
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	NPHP4 FAAH FANCA AP2A2 TELO2 DMRT1 PRRC2A BIN1 CELSR3 TLN1 GREB1 PATJ MUC1 HCFC1	7.07e-07	198	314	14	7035_UP
Drug	Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	ZHX3 RABGAP1 JAK2 PLA2G6 MERTK RAD51 BIN1 PHTF2 APOE SLC9A2 EVA1B PATJ NFAT5	2.70e-06	191	314	13	3605_DN
Drug	Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A	RABGAP1 MAST2 TLN2 TACC1 ANK3 WDR91 PACS1 ELF1 BICRAL CEP152 GREB1 NFAT5 MUC1	3.21e-06	194	314	13	3303_DN
Drug	Iohexol [66108-95-0]; Up 200; 4.8uM; PC3; HT_HG-U133A	ZHX3 MANBA R3HCC1L AP2A2 LIPG COBL DOCK6 VCAN TTLL4 CD40LG HCFC1 CPEB1 KIF1C	3.21e-06	194	314	13	4643_UP
Drug	Praziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A	STAM2 ITPRID2 PLD3 FAAH UBXN6 REST PACS1 FAM169A ADGRE5 SNAPC4 PATJ DNAAF1 MUC1	3.60e-06	196	314	13	7228_DN
Drug	Enalapril maleate [76095-16-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A	PHF8 MAST2 MAP3K1 AP2A2 CACNA1I DOCK6 DSC2 UBXN6 YTHDC2 PACS1 CD44 NFAT5 HCFC1	4.02e-06	198	314	13	7428_UP
Drug	Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A	MANBA VWA8 RABGAP1 PLD3 MAST2 AP2A2 RPRD2 HSPG2 BIN1 WDR91 PACS1 MUC1 KIF1C	4.02e-06	198	314	13	4805_DN
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; MCF7; HT_HG-U133A	PGR JAK2 EPS15L1 PTPRS KCNH1 COL14A1 BIN1 AFF2 GRIA4 GRIN2C VCAN CTSE EPAS1	4.25e-06	199	314	13	4810_UP
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	CCP110 ZHX3 ZFYVE16 PLD3 ALMS1 AHNAK SYNE2 TACC1 YTHDC2 CD44 FAM169A MACF1	1.47e-05	191	314	12	4168_DN
Drug	Kainic Acid	MYO9A JAK2 PKP2 PPP1R9B C4B GRIA4 GRIN2B GRIN2C REST APOE ADNP ATF7IP	1.72e-05	194	314	12	ctd:D007608
Drug	Imidurea [39236-46-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A	AADAC PHF8 FANCA PTPRS MAGEC1 JADE2 DOCK9 NUP214 TGM2 MUC1 HCFC1 CPEB1	1.81e-05	195	314	12	3522_UP
Drug	panobinostat	STAM2 SALL3 ANKS1B SMOC1 PFKP RBMS3 AHNAK PKM COBL COL14A1 TACC1 PHIP CNTN2 PRUNE2 LRP12 RARRES2 DSC2 FAM13C JADE2 FAT3 DOCK9 LAMA2 PHTF2 POU5F1 REST CR1L KCNV1 KAT7 ZNF750 PIEZO2 ZNF827 ARID2 CD44 ELF1 MYOCD PATJ MUC4 EPAS1	1.83e-05	1333	314	38	ctd:C496932
Drug	1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one	ANKS1B ITPRID2 AHNAK CAMTA1 AMOTL2 HSPG2 FLNA TTYH2 REST KCNH3 KCNV1 TLN1 CNTNAP4 ADGRE5 EPAS1 CPEB1 KIF1C	1.88e-05	373	314	17	ctd:C540355
Drug	N-Acetyl-L-leucine [1188-21-2]; Down 200; 23uM; MCF7; HT_HG-U133A	ITPRID2 PLD3 TLN2 MERTK BIN1 DSC2 NECAP2 CD44 SAFB2 CDC25A PADI2 HCFC1	1.91e-05	196	314	12	6462_DN
Drug	Amethopterin (R,S) [59-05-2]; Up 200; 8.8uM; MCF7; HT_HG-U133A	MAP3K1 TLN2 PRUNE2 LRP12 BIN1 AFF2 JADE2 DOCK9 GRIN2B AFAP1 VCAN HCFC1	2.01e-05	197	314	12	3214_UP
Drug	Meprylcaine hydrochloride [956-03-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A	SVEP1 PASK AP2A2 MTMR3 DSC2 PHTF2 CD44 ADGRE5 BICRAL SNAPC4 CDC25A HCFC1	2.01e-05	197	314	12	6204_UP
Drug	Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A	TRAF3IP2 PGR PASK AP2A2 TACC1 RAD51 DSC2 PRR36 DOCK9 ADGRG2 HCFC1 KIF1C	2.01e-05	197	314	12	3202_DN
Drug	Enoxacin [74011-58-8]; Up 200; 12.4uM; MCF7; HT_HG-U133A	CYP2C9 EXTL1 SVEP1 PRUNE2 RARRES2 JADE2 GRIN2C EVA1B GREB1 NUP188 CDC25A CDH4	2.01e-05	197	314	12	5616_UP
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A	MAST2 MAP3K1 F11R AP2A2 TACC1 TGM2 EVA1B ADGRG2 VCAN CD44 GREB1 HCFC1	2.11e-05	198	314	12	6031_DN
Drug	1,10-diaminodecane	HOXD13 GRIN2B GRIN2C TGM2	2.30e-05	13	314	4	CID000001317
Drug	Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; PC3; HG-U133A	GAK RBMS3 MED13 PADI1 HSPG2 LRP12 APOE NUBPL MST1R EVA1B ANKRD11 NFAT5	2.33e-05	200	314	12	1915_DN
Drug	Succimer	ERBB4 HIVEP1 ZNF148 ZFYVE16 SMOC1 PLD3 BLM JAK2 ZBP1 TSC22D1 PTPRC ATXN1 AHNAK PIP5K1B COL14A1 PLCB4 PHIP MED13 MOCOS MUC20 ANK3 DSC2 FAM13C JADE2 WWP1 REST PRPF40A DNAJC2 KAT7 TGM2 PIEZO2 EVA1B N4BP2 CD44 NFAT5 PADI2	3.15e-05	1264	314	36	ctd:D004113
Drug	ketobemidone	CYP2C19 GRIA4 GRIN2B GRIN2C PNMA2	4.37e-05	29	314	5	CID000010101
Drug	Implanon	CYP2C19 CYP2C9 PGR SAFB ADGRG2 SAFB2	4.38e-05	47	314	6	CID000040976
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A	GMEB2 SAFB RPRD2 PRRC2A PHIP MED13 MOCOS JADE2 ADNP DNAJC2 PPP1R8	4.76e-05	182	314	11	1951_DN
Drug	Ellipticine [519-23-3]; Down 200; 16.2uM; MCF7; HT_HG-U133A	TRAF3IP2 STAM2 NACA LCMT2 FBXO34 ADNP PPP1R8 ELF1 NFAT5 SON BORA	4.76e-05	182	314	11	6253_DN
Drug	tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA	ZNF148 LCMT2 MED13 FBXO34 JADE2 ZCCHC8 WWP1 ADNP PALB2 CDC25A SON	5.53e-05	185	314	11	1114_DN
Drug	T2755	CYP2C19 SCN9A GRIA4 GRIN2B GRIN2C EEF1B2 ADGRE5	5.54e-05	71	314	7	CID000005514
Drug	GW8510; Down 200; 10uM; MCF7; HT_HG-U133A	TRAF3IP2 LCMT2 BLM AMOTL2 FBXO34 NOL8 ZCCHC8 ADNP PALB2 ATF7IP ELF1	6.09e-05	187	314	11	7080_DN
Drug	Magnetite Nanoparticles	ERBB4 HIVEP1 ZNF148 ZFYVE16 SMOC1 PLD3 BLM JAK2 ZBP1 TSC22D1 PTPRC ATXN1 AHNAK PIP5K1B COL14A1 PLCB4 PHIP MED13 MOCOS MUC20 ANK3 DSC2 FAM13C JADE2 WWP1 REST PRPF40A DNAJC2 KAT7 TGM2 PIEZO2 EVA1B N4BP2 CD44 NFAT5 PADI2	6.57e-05	1310	314	36	ctd:D058185
Drug	butylparaben	ERBB4 FAAH PGR CACNA1I NTRK1 GRIA4 GRIN2B GRIN2C CD44 CNTN3	6.77e-05	157	314	10	ctd:C038091
Drug	sodium chlorate	LIPG SELPLG LRP12 APOE MST1R CD44	7.01e-05	51	314	6	CID000516902
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	MYO9A ITPRID2 FBXL4 TELO2 RAD51 JADE2 PHTF2 MPHOSPH8 SNAPC4 CDC25A MUC1	7.03e-05	190	314	11	1044_DN
Drug	Rimexolone [49697-38-3]; Up 200; 10.8uM; HL60; HT_HG-U133A	FAAH MAP3K1 PTPRS DOCK6 BIN1 YTHDC2 APOE CEP164 CELSR3 ADGRG2 PADI2	7.37e-05	191	314	11	2955_UP
Drug	enzacamene	ERBB4 PGR CACNA1I NTRK1 GRIA4 GRIN2B GRIN2C CD44 CNTN3	7.76e-05	129	314	9	ctd:C038939
Drug	Androgen Antagonists	ERBB4 PGR CACNA1I NTRK1 GRIA4 CD44 CNTN3	7.90e-05	75	314	7	ctd:D000726
Drug	(+/-)-blebbistatin; Up 200; 17uM; MCF7; HT_HG-U133A_EA	RABGAP1 NPHP4 PGR FANCA ATXN1 EVA1B CELSR3 CD44 ADGRE5 CEP152 KIF1C	8.47e-05	194	314	11	954_UP
Drug	Glycopyrrolate [596-51-0]; Up 200; 10uM; MCF7; HT_HG-U133A	PLA2G6 DSC2 ICAM2 LAMA2 PHTF2 YTHDC2 CEP164 ZNF750 ADGRG2 VCAN CDH4	8.47e-05	194	314	11	4709_UP
Drug	Thiamine hydrochloride [67-03-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A	ZFYVE16 RABGAP1 ALMS1 TACC1 SLC2A8 PACS1 EVA1B SAFB2 PATJ DNAAF1 NFAT5	8.47e-05	194	314	11	7479_DN
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A	ZHX3 STAM2 PHF8 PGR DOCK6 BIN1 TLN1 FAM169A SAFB2 MACF1 PATJ	8.47e-05	194	314	11	5641_DN
Drug	Tridihexethyl chloride; Up 200; 11.4uM; MCF7; HT_HG-U133A	MAST2 AP2B1 PLA2G6 DOCK6 PRRC2A PRR36 DOCK9 ADGRE5 MUC1 HCFC1 KIF1C	8.47e-05	194	314	11	3526_UP
Drug	Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; MCF7; HT_HG-U133A	STAM2 MANBA PLD3 MAST2 AP2A2 PLA2G6 RAD51 UBXN6 RBM12 ADGRG2 AQR	8.47e-05	194	314	11	3509_DN
Drug	Piromidic acid [19562-30-2]; Up 200; 13.8uM; PC3; HT_HG-U133A	ZHX3 COBL COL14A1 TLN2 PLA2G6 APOE CEP164 PACS1 AFAP1 PRKG1 SNAPC4	8.47e-05	194	314	11	4575_UP
Drug	radicicol; Up 200; 0.1uM; PC3; HT_HG-U133A	STAM2 ITPRID2 GMEB2 PHF8 EPS15L1 AHNAK SCN9A CACNA1I AFF2 TGM2 PATJ	8.87e-05	195	314	11	5952_UP
Drug	Flumethasone [2135-17-3]; Up 200; 9.8uM; PC3; HT_HG-U133A	ZHX3 TRO AP2B1 AFF2 RARRES2 PRR36 JADE2 REST CEP164 KCNV1 CEP152	8.87e-05	195	314	11	3712_UP
Drug	Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; MCF7; HT_HG-U133A	STAM2 MAP3K1 SYNE2 TACC1 MERTK LRP12 BIN1 CEP164 TTLL4 NUP188 CDC25A	8.87e-05	195	314	11	4393_DN
Drug	Reserpinic acid hydrochloride; Up 200; 9.2uM; MCF7; HT_HG-U133A	MTMR3 TLN2 PLA2G6 PRUNE2 LRP12 BIN1 RARRES2 PELI1 EVA1B CD44 MUC1	8.87e-05	195	314	11	7323_UP
Drug	chromomycin A3	PFKM BLM CNTN2 GRIN2B REST APOE PRPF40A TGM2	9.15e-05	103	314	8	CID000656673
Drug	Phenazopyridine hydrochloride [136-40-3]; Up 200; 16uM; PC3; HT_HG-U133A	CYP2C9 JAK2 PASK COL14A1 PRUNE2 DOCK9 APOE TGM2 CELSR3 PRKG1 ATP1A2	9.29e-05	196	314	11	5758_UP
Drug	BAS 012416453; Up 200; 38uM; MCF7; HT_HG-U133A	ZHX3 MYO9A MAP3K1 PGR AP2A2 TLN2 BIN1 ANK3 UBXN6 REST PATJ	9.29e-05	196	314	11	6880_UP
Drug	Hydrocortisone base [50-23-7]; Down 200; 11uM; MCF7; HT_HG-U133A	RABGAP1 PLD3 MAST2 F11R PLA2G6 DOCK6 TGM2 AFAP1 TLN1 SAFB2 MUC1	9.29e-05	196	314	11	3284_DN
Drug	Chlorzoxazone [95-25-0]; Up 200; 23.6uM; MCF7; HT_HG-U133A	PGR CACNA1I PADI1 RARRES2 DSC2 GRIN2C AFAP1 TTLL4 GREB1 TRAF3IP3 CDC25A	9.29e-05	196	314	11	2263_UP
Drug	Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; PC3; HT_HG-U133A	STAM2 GMEB2 F11R AP2B1 LRP12 BIN1 WDR91 VCAN FAM169A BICRAL MUC1	9.29e-05	196	314	11	2065_DN
Drug	Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A	ZFYVE16 PLD3 FANCA TELO2 RPRD2 DOCK6 PHTF2 NFAT5 AQR CPEB1 KIF1C	9.29e-05	196	314	11	1821_DN
Drug	estradiol; Up 200; 0.01uM; PC3; HT_HG-U133A	TRO EPS15L1 DOCK6 BIN1 RASGRF1 ICAM2 GRIA4 CEP152 PATJ CDC25A CPEB1	9.29e-05	196	314	11	5910_UP
Drug	Bromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A	RUSC2 AP2A2 COL14A1 ADGRF5 PADI1 LRP12 BIN1 LLGL1 DCHS1 MUC4 KIF1C	9.29e-05	196	314	11	4741_UP
Drug	Dequalinium dichloride [522-51-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A	ZHX3 RABGAP1 RUSC2 ALMS1 AP2B1 PTPRS AMOTL2 DSC2 JADE2 GUCY2D KIF1C	9.29e-05	196	314	11	2631_UP
Drug	Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A	TRAF3IP2 HIVEP1 SVEP1 LIPG SCN9A MERTK DOCK6 YTHDC2 VCAN PNMA2 MUC1	9.29e-05	196	314	11	5757_DN
Drug	Zardaverine [101975-10-4]; Down 200; 15uM; MCF7; HT_HG-U133A	GMEB2 PLD3 FAAH KATNIP TACC1 PHTF2 WDR91 TGM2 EVA1B CD44 DNAAF1	9.72e-05	197	314	11	7347_DN
Drug	Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; MCF7; HT_HG-U133A	EXTL1 PHF8 EPS15L1 PTPRS MERTK RAD51 BIN1 GRIN2B ADGRG2 FAM169A HCFC1	9.72e-05	197	314	11	6265_UP
Drug	Theobromine [83-67-0]; Up 200; 22.2uM; MCF7; HT_HG-U133A	TRO SVEP1 DMRT1 PRUNE2 LRP12 DSC2 LAMA2 YTHDC2 MST1R TGM2 SAFB2	9.72e-05	197	314	11	3334_UP
Drug	Trolox [53188-07-1]; Up 200; 16uM; PC3; HT_HG-U133A	CCP110 IL16 PASK TLN2 PELI1 SLC9A2 PATJ MUC1 MUC4 EPAS1 CPEB1	9.72e-05	197	314	11	7304_UP
Drug	Tinidazole [19387-91-8]; Up 200; 16.2uM; HL60; HT_HG-U133A	PHF8 EPS15L1 PRUNE2 BIN1 ANK3 LAMA2 PACS1 SLC9A2 VCAN CDH4 HCFC1	9.72e-05	197	314	11	2568_UP
Drug	clozapine; Up 200; 10uM; HL60; HT_HG-U133A	STAM2 HOXD13 ADGRF5 PLAAT1 ANK3 RASGRF1 GRIN2C SLC9A2 LLGL1 GREB1 MUC4	9.72e-05	197	314	11	2689_UP
Drug	Nadide [53-84-9]; Up 200; 6uM; MCF7; HT_HG-U133A	IL16 CYP2C9 MAP3K1 KCNH1 ADGRF5 PRUNE2 DOCK9 LAMA2 TGM2 LLGL1 MUC4	9.72e-05	197	314	11	6091_UP
Drug	Ethamivan [304-84-7]; Up 200; 18uM; MCF7; HT_HG-U133A	TRO PASK EPS15L1 ALMS1 APOE PACS1 EVA1B MACF1 ADGRE5 MUC4 HCFC1	9.72e-05	197	314	11	7021_UP
Drug	Phenelzine sulfate [156-51-4]; Up 200; 17uM; HL60; HT_HG-U133A	AP2A2 HOXD13 DMRT1 SELPLG LRP12 BIN1 AFF2 APOE LLGL1 VCAN SAFB2	9.72e-05	197	314	11	2357_UP
Drug	Flurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A	PHF8 AFF2 FAM13C DOCK9 CEP164 ZNF750 TGM2 ADGRG2 PEAK1 ATP1A2 KIF1C	9.72e-05	197	314	11	4702_UP
Drug	Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; PC3; HT_HG-U133A	TRAF3IP2 RABGAP1 SVEP1 AP2A2 LIPG TLN2 KATNIP MERTK PADI1 YTHDC2 KIF1C	9.72e-05	197	314	11	5735_DN
Drug	Butylparaben [94-26-8]; Up 200; 20.6uM; MCF7; HT_HG-U133A	STAM2 MANBA PGR JAK2 LRP12 FAM13C TGM2 CD44 SAFB2 TRAF3IP3 MUC4	1.02e-04	198	314	11	6446_UP
Drug	S(-)-terguride hydrogen maleate [37686-85-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A	MAP3K1 AP2A2 PLA2G6 CACNA1I PADI1 BIN1 DSC2 AFAP1 SAFB2 HCFC1 AQR	1.02e-04	198	314	11	6473_DN
Drug	Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A	RAD51 LRP12 BIN1 DSC2 PRR36 DOCK9 APOE PACS1 TGM2 GREB1 CDH4	1.02e-04	198	314	11	6778_UP
Drug	Benzocaine [94-09-7]; Down 200; 24.2uM; MCF7; HT_HG-U133A	MANBA MTMR3 TLN2 PADI1 BIN1 DSC2 DOCK9 PACS1 ZNF750 TGM2 CD44	1.02e-04	198	314	11	4808_DN
Drug	Ribostamycin sulfate salt [53797-35-6]; Up 200; 7.2uM; MCF7; HT_HG-U133A	ITPRID2 FANCA JAK2 RAD51 PRR36 YTHDC2 PACS1 TGM2 VCAN CDC25A HCFC1	1.02e-04	198	314	11	6765_UP
Drug	Merbromin [129-16-8]; Down 200; 5uM; MCF7; HT_HG-U133A	MANBA FAAH R3HCC1L MTMR3 COL14A1 WDR7 CEP164 WDR91 CD44 PATJ HCFC1	1.02e-04	198	314	11	4722_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	TRAF3IP2 ZHX3 MAST2 R3HCC1L ALMS1 AP2A2 LRP12 DSC2 JADE2 TGM2 SLC9A2	1.02e-04	198	314	11	4348_DN
Drug	Bicuculline (+) [485-49-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A	FANCA MTMR3 PLA2G6 MERTK CEP164 AFAP1 NECAP2 TTLL4 MACF1 NUP188 HCFC1	1.02e-04	198	314	11	4397_DN
Drug	Bromopride [4093-35-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	SVEP1 FAAH PLA2G6 CACNA1I PADI1 LRP12 APOE AFAP1 CD44 ADGRE5 GREB1	1.02e-04	198	314	11	6037_DN
Drug	Iopamidol [60166-93-0]; Up 200; 5.2uM; PC3; HT_HG-U133A	PASK PLA2G6 ADGRF5 PRUNE2 BIN1 DOCK9 PHTF2 APOE LLGL1 PNMA2 SNAPC4	1.02e-04	198	314	11	5832_UP
Drug	Pyrimethamine [58-14-0]; Down 200; 16uM; PC3; HT_HG-U133A	PLD3 PASK HOXD13 TLN2 PLA2G6 RPRD2 BIN1 PACS1 TLN1 MUC1 EPAS1	1.02e-04	198	314	11	4194_DN
Drug	Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; PC3; HT_HG-U133A	EXTL1 MAP3K1 PASK LLGL1 VCAN PRKG1 SNAPC4 DNAAF1 NFAT5 HCFC1 CPEB1	1.02e-04	198	314	11	6640_UP
Drug	Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; HL60; HT_HG-U133A	TRO TLN2 ADGRF5 CCL8 DOCK6 ANK3 REST ZNF750 EVA1B LLGL1 HCFC1	1.02e-04	198	314	11	2549_UP
Drug	SC-58125; Up 200; 10uM; MCF7; HG-U133A	ZHX3 KLHL35 NPHP4 F11R HOXD13 BIN1 SLC2A8 NUP214 REST PRKG1 NFAT5	1.06e-04	199	314	11	254_UP
Drug	Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; HL60; HG-U133A	TRAF3IP2 NACA MAST2 JAK2 FLNA RANBP2 UBXN6 ANKRD17 MACF1 NFAT5 SON	1.06e-04	199	314	11	1994_UP
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Up 200; 25.2uM; PC3; HT_HG-U133A	PASK RBMS3 PRUNE2 HSPG2 PLAAT1 AFF2 NUP214 KCNV1 TLN1 CTSE KIF1C	1.06e-04	199	314	11	4311_UP
Drug	Ketoprofen [22071-15-4]; Up 200; 15.8uM; HL60; HT_HG-U133A	IL16 ZFYVE16 FANCA AHNAK PLA2G6 MERTK BIN1 SLC2A8 REST TGM2 TRAF3IP3	1.06e-04	199	314	11	2354_UP
Drug	Trimetazidine dihydrochloride [13171-25-0]; Down 200; 11.8uM; HL60; HG-U133A	ZFYVE16 NACA MAST2 PASK ALMS1 AP2B1 MOCOS LRP12 WWP1 SNAPC4 HCFC1	1.06e-04	199	314	11	1727_DN
Drug	Yohimbinic acid monohydrate [27801-27-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	ZHX3 MAST2 MTMR3 HSPG2 CEP164 WDR91 EVA1B SAFB2 ADGRE5 DNAAF1 KIF1C	1.06e-04	199	314	11	2803_DN
Drug	Pheniramine maleate [132-20-7]; Down 200; 11.2uM; PC3; HT_HG-U133A	TRAF3IP2 MANBA PLD3 RUSC2 R3HCC1L PADI1 HSPG2 SLC2A8 PATJ EPAS1 CPEB1	1.06e-04	199	314	11	4012_DN
Drug	Isoflupredone acetate [338-98-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A	STAM2 IL16 JAK2 PTPRS MTMR3 RAD51 PLAAT1 DSC2 NUP214 ZNF750 AFAP1	1.06e-04	199	314	11	5545_UP
Drug	Diflunisal [22494-42-4]; Down 200; 16uM; MCF7; HT_HG-U133A	STAM2 VWA8 MYO9A PLD3 AP2A2 PRR36 PHTF2 TTLL4 MACF1 PATJ CDC25A	1.11e-04	200	314	11	1490_DN
Drug	2-Chloropyrazine [14508-49-7]; Down 200; 35uM; PC3; HT_HG-U133A	PLD3 MAST2 SVEP1 ALMS1 AP2A2 SCN9A COBL DSC2 PNMA2 SNAPC4 CPEB1	1.11e-04	200	314	11	5750_DN
Drug	Amidopyrine [58-15-1]; Down 200; 17.2uM; HL60; HG-U133A	TSC22D1 ALMS1 RBMS3 RPRD2 TMEM184B MED13 PADI1 WDR7 ZCCHC8 HCFC1 SON	1.11e-04	200	314	11	1376_DN
Drug	Netilmicin sulfate [56931-57-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A	ZHX3 MAST2 AP2A2 PTPRS LRP12 ANK3 APOE FAM169A SAFB2 GREB1 AQR	1.11e-04	200	314	11	6005_DN
Drug	orphenadrine	CYP2C19 CYP2C9 SCN9A GRIN2B GRIN2C PNMA2	1.19e-04	56	314	6	CID000004601
Drug	leucine methyl ester	PTPRC GLUD2 MOCOS AFF2 PNMA2	1.28e-04	36	314	5	CID000065105
Drug	octylmethoxycinnamate	ERBB4 PGR CACNA1I NTRK1 GRIA4 GRIN2B GRIN2C CD44 CNTN3	1.38e-04	139	314	9	ctd:C118580
Drug	6-chloroquinoxaline-2,3-diol	GLUD2 GRIN2B GRIN2C	1.38e-04	8	314	3	CID000081143
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	TRAF3IP2 HIVEP1 GMEB2 RPRD2 JADE2 DOCK9 ADNP GREB1 NUP188 PATJ	1.44e-04	172	314	10	5903_DN
Disease	lung carcinoma (is_marker_for)	JAK2 MDC1 MUC4	1.11e-05	5	308	3	DOID:3905 (is_marker_for)
Disease	alpha synuclein measurement	PNPT1 RBMS3 OXSR1 ENAH	3.17e-05	18	308	4	EFO_0009323
Disease	familial atrial fibrillation	ERBB4 CYP2C19 NACA BEST3 ATXN1 SYNE2 PKP2 HSPG2 MYOCD	4.08e-05	156	308	9	C3468561
Disease	Persistent atrial fibrillation	ERBB4 CYP2C19 NACA BEST3 ATXN1 SYNE2 PKP2 HSPG2 MYOCD	4.08e-05	156	308	9	C2585653
Disease	Paroxysmal atrial fibrillation	ERBB4 CYP2C19 NACA BEST3 ATXN1 SYNE2 PKP2 HSPG2 MYOCD	4.08e-05	156	308	9	C0235480
Disease	Atrial Fibrillation	ERBB4 CYP2C19 NACA BEST3 ATXN1 SYNE2 PKP2 HSPG2 MYOCD	4.98e-05	160	308	9	C0004238
Disease	body fat percentage	HIVEP1 ANKS1B FANCA PLA2G6 CAMTA1 PRRC2A IQCH ZCCHC8 PHTF2 APOE MST1R PACS1 MACF1 IGSF9B PATJ NFAT5	6.28e-05	488	308	16	EFO_0007800
Disease	Malignant neoplasm of breast	MAGEA4 ERBB4 FSCB FAAH MAP3K1 PGR PTPRC KCNH1 SYNE2 MTMR3 PRRC2A MAGEC2 RAD51 FOXM1 FLNA LAMA2 NUP214 PALB2 MRPS7 TGM2 EEF1B2 SLC9A2 LLGL1 N4BP2 NUP133 MACF1	6.90e-05	1074	308	26	C0006142
Disease	uric acid measurement	ZHX3 ERBB4 MYO9A QRICH2 HSF5 FANCA KIAA0319 PIP5K1B OXSR1 NTRK1 FAT3 APOE PACS1 ZNF827 GUCY2D NFAT5 MUC1 EPAS1	8.52e-05	610	308	18	EFO_0004761
Disease	Leukemia, Myelocytic, Acute	FANCA BLM JAK2 KMT2C RAD51 NUP214 PALB2 ENAH CD44	9.09e-05	173	308	9	C0023467
Disease	esophagus squamous cell carcinoma (is_implicated_in)	ERBB4 MAP3K1 FANCA KMT2C COL14A1	1.04e-04	45	308	5	DOID:3748 (is_implicated_in)
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	LIPG SYNE2 PCSK9 LLGL1 MACF1 MUC1 CEACAM20	1.06e-04	103	308	7	EFO_0008595, EFO_0020944
Disease	reticulocyte count	VWA8 GMEB2 PFKM MAST2 MAP3K1 SYCE2 PTPRC AP2B1 ATXN1 AHNAK SYNE2 PKD1 MTMR3 TLN2 PLA2G6 C4B AMOTL2 FBXO34 ZCCHC8 REST APOE SLC45A4 TMX2 EEF1B2 KIF1C	1.15e-04	1045	308	25	EFO_0007986
Disease	Acute monocytic leukemia	FANCA BLM RAD51 PALB2	1.45e-04	26	308	4	C0023465
Disease	Hand-foot syndrome, response to fluoropyrimidines	RBMS3 PHIP CDH4	1.75e-04	11	308	3	EFO_0010825, EFO_1001893
Disease	sphingomyelin measurement	LIPG SYNE2 DOCK6 USH2A SDK1 PCSK9 APOE KCNH3 PELP1 ANKRD11 CEACAM20	1.80e-04	278	308	11	EFO_0010118
Disease	level of Sphingomyelin (d42:2) in blood serum	PCSK9 APOE PELP1 ANKRD17	2.25e-04	29	308	4	OBA_2045183
Disease	Miller Dieker syndrome	FANCA BLM RAD51 PALB2	2.25e-04	29	308	4	C0265219
Disease	level of Sphingomyelin (d38:1) in blood serum	SYNE2 PCSK9 PELP1 ANKRD17	2.58e-04	30	308	4	OBA_2045180
Disease	Abnormality of refraction	ZHX3 SNAP91 RBMS3 MTMR3 COBL PLA2G6 MOCOS ANK3 RASGRF1 FAT3 LAMA2 GRIA4 GRIN2B APOE SLC45A4 FER1L4 ARID2 PEAK1	2.84e-04	673	308	18	HP_0000539
Disease	homostachydrine measurement	ERBB4 PLCB4 EYS	2.98e-04	13	308	3	EFO_0021164
Disease	Sphingomyelin (d18:1/21:0, d17:1/22:0, d16:1/23:0) measurement	SYNE2 APOE	3.24e-04	3	308	2	EFO_0022111
Disease	Bicuspid aortic valve	HMCN2 MUC4	3.24e-04	3	308	2	HP_0001647
Disease	X-21258 measurement	CYP2C19 CYP2C9	3.24e-04	3	308	2	EFO_0800802
Disease	Pregnancy Complications	FAAH JAK2	3.24e-04	3	308	2	C0032962
Disease	Waardenburg Anophthalmia Syndrome	SMOC1 FNBP4	3.24e-04	3	308	2	C0599973
Disease	N-palmitoyl-sphinganine (d18:0/16:0) measurement	SYNE2 APOE	3.24e-04	3	308	2	EFO_0800428
Disease	level of Sphingomyelin (d40:1) in blood serum	PCSK9 APOE PELP1 ANKRD17	3.32e-04	32	308	4	OBA_2045182
Disease	esterified cholesterol measurement	LIPG DOCK6 PCSK9 APOE LLGL1 ANKRD17 CEACAM20	4.06e-04	128	308	7	EFO_0008589
Disease	platelet component distribution width	SVEP1 PTPRC AP2B1 NFE2L1 PIP5K1B PPP1R9B PLA2G6 ADGRF5 CAMTA1 PRRC2A PRUNE2 JADE2 DOCK9 WBP2NL APOE TLN1 MACF1 ADGRE5 EPAS1	4.12e-04	755	308	19	EFO_0007984
Disease	bipolar disorder	ANKS1B ANKHD1 SVEP1 SNAP91 RBMS3 NFE2L1 IQCH ANK3 JADE2 PALB2 SLC45A4 PACS1 TMEM108 BICRAL IGSF9B EPAS1	4.16e-04	577	308	16	MONDO_0004985
Disease	Germ Cell Cancer	DMRT1 POU5F1 ATF7IP	4.67e-04	15	308	3	C0740345
Disease	Germ cell tumor	DMRT1 POU5F1 ATF7IP	4.67e-04	15	308	3	C0205851
Disease	Neoplasms, Embryonal and Mixed	DMRT1 POU5F1 ATF7IP	4.67e-04	15	308	3	C0205852
Disease	Cancer, Embryonal	DMRT1 POU5F1 ATF7IP	4.67e-04	15	308	3	C0751364
Disease	Cancer, Embryonal and Mixed	DMRT1 POU5F1 ATF7IP	4.67e-04	15	308	3	C0751365
Disease	Embryonal Neoplasm	DMRT1 POU5F1 ATF7IP	4.67e-04	15	308	3	C0027654
Disease	Neoplasms, Germ Cell and Embryonal	DMRT1 POU5F1 ATF7IP	4.67e-04	15	308	3	C0027658
Disease	response to olanzapine	HIVEP1 ANKS1B ATP1A2	4.67e-04	15	308	3	GO_0097333
Disease	Myopia	RASGRF1 LAMA2 GRIA4	4.67e-04	15	308	3	C0027092
Disease	multiple sclerosis	ZHX3 MANBA VWA8 JAK2 EPS15L1 ATXN1 LIPG MERTK RASGRF1 JADE2 UBXN6 SCAMP2 NUBPL CR1L NCOA5 N4BP2	5.69e-04	594	308	16	MONDO_0005301
Disease	Neuralgia, Supraorbital	SCN9A NTRK1 PRKG1	5.70e-04	16	308	3	C0038870
Disease	level of Sterol ester (27:1/18:1) in blood serum	PCSK9 APOE ANKRD17	5.70e-04	16	308	3	OBA_2045195
Disease	Paroxysmal Nerve Pain	SCN9A NTRK1 PRKG1	5.70e-04	16	308	3	C0751373
Disease	Nerve Pain	SCN9A NTRK1 PRKG1	5.70e-04	16	308	3	C0751372
Disease	Neuralgia, Ilioinguinal	SCN9A NTRK1 PRKG1	5.70e-04	16	308	3	C0751371
Disease	Neuralgia	SCN9A NTRK1 PRKG1	5.70e-04	16	308	3	C0027796
Disease	Neuralgia, Atypical	SCN9A NTRK1 PRKG1	5.70e-04	16	308	3	C0234247
Disease	Neuralgia, Stump	SCN9A NTRK1 PRKG1	5.70e-04	16	308	3	C0234249
Disease	Neuralgia, Iliohypogastric Nerve	SCN9A NTRK1 PRKG1	5.70e-04	16	308	3	C0423712
Disease	Neuralgia, Perineal	SCN9A NTRK1 PRKG1	5.70e-04	16	308	3	C0423711
Disease	Neuralgia, Vidian	SCN9A NTRK1 PRKG1	5.70e-04	16	308	3	C0042656
Disease	aspartate aminotransferase measurement	RABGAP1 PTPRC HMCN2 ATXN1 RBMS3 NFE2L1 PKM MERTK PRRC2A PHIP CNTN2 MOCOS BIN1 MUC19 NUP214 APOE SLC45A4 TMX2 WDR91 ZNF827 ELF1	5.90e-04	904	308	21	EFO_0004736
Disease	Sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) measurement	SYNE2 APOE	6.43e-04	4	308	2	EFO_0022112
Disease	Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) measurement	SYNE2 APOE	6.43e-04	4	308	2	EFO_0022116
Disease	glycogen storage disease (implicated_via_orthology)	PFKM PFKP	6.43e-04	4	308	2	DOID:2747 (implicated_via_orthology)
Disease	palmitoyl sphingomyelin (d18:1/16:0) measurement	PCSK9 APOE	6.43e-04	4	308	2	EFO_0800300
Disease	pancreatic cancer (is_marker_for)	NTRK1 MUC16 APOE ADGRE5 MUC1 MUC4	6.80e-04	101	308	6	DOID:1793 (is_marker_for)
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	LIPG APOE LLGL1 MACF1 CEACAM20	6.83e-04	67	308	5	EFO_0008595, EFO_0020946
Disease	Fetal Alcohol Syndrome	ANK3 REST ADNP	6.87e-04	17	308	3	C0015923
Disease	refractive error	PNPT1 SNAP91 CACNA1I ANK3 RASGRF1 LAMA2 GRIA4 GRIN2B APOE FER1L4 GUCY2D	6.88e-04	326	308	11	MONDO_0004892
Disease	pulse pressure measurement	STAM2 CYP2C9 RABGAP1 PFKM MAST2 SVEP1 PNPT1 PRPF40B ATXN1 PXDNL PKD1 TLN2 IQCH WDR7 FAT3 PHTF2 APOE CR1L CEP164 PIEZO2 AFAP1 FAM171A2 ZNF827 ANKRD11 CDC25A NFAT5 HCFC1 HYDIN	7.49e-04	1392	308	28	EFO_0005763
Disease	reticulocyte measurement	VWA8 PFKM MAP3K1 SYCE2 PTPRC AP2B1 ATXN1 AHNAK SYNE2 MTMR3 TLN2 OXSR1 AMOTL2 FBXO34 FLNA ZCCHC8 POU5F1 REST APOE SLC45A4 PACS1 EEF1B2 ZNF827	7.57e-04	1053	308	23	EFO_0010700
Disease	Myopia	ANKS1B KATNIP LRP12 RASGRF1 DOCK9 LAMA2 GRIA4 GRIN2B FER1L4 ENAH CNTNAP4 IGSF9B	7.99e-04	385	308	12	HP_0000545
Disease	level of Sphingomyelin (d34:1) in blood serum	PCSK9 APOE ANKRD17	8.18e-04	18	308	3	OBA_2045175
Disease	Malignant neoplasm of prostate	DCAF6 IL16 CYP2C19 MAP3K1 JAK2 KMT2C PTPRC RPRD2 NOL8 JADE2 PCDH11Y PALB2 ARID2 GREB1 PATJ MUC4	8.36e-04	616	308	16	C0376358
Disease	Prostatic Neoplasms	DCAF6 IL16 CYP2C19 MAP3K1 JAK2 KMT2C PTPRC RPRD2 NOL8 JADE2 PCDH11Y PALB2 ARID2 GREB1 PATJ MUC4	8.36e-04	616	308	16	C0033578
Disease	C-reactive protein measurement	TRAF3IP2 GIMAP4 ERBB4 HSF5 MAP3K1 FANCA LIPG AHNAK PKD1 PLA2G6 CAMTA1 MERTK BIN1 ANK3 YTHDC2 APOE MST1R PACS1 LLGL1 MACF1 SNAPC4 PATJ NFAT5 CDH4 CEACAM20	9.46e-04	1206	308	25	EFO_0004458
Disease	systemic lupus erythematosus (implicated_via_orthology)	TRAF3IP2 PTPRC C4A C4B	1.04e-03	43	308	4	DOID:9074 (implicated_via_orthology)
Disease	Sphingomyelin (d18:1/20:0, d16:1/22:0) measurement	SYNE2 APOE	1.06e-03	5	308	2	EFO_0022109
Disease	Hereditary Sensory Autonomic Neuropathy, Type 2	SCN9A NTRK1	1.06e-03	5	308	2	C0020072
Disease	free cholesterol measurement	LIPG PCSK9 FNBP4 APOE LLGL1 CEACAM20	1.22e-03	113	308	6	EFO_0008591
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	LIPG SYNE2 PLA2G6 PCSK9 APOE MACF1 NFAT5 CEACAM20	1.26e-03	200	308	8	EFO_0004611, EFO_0020945
Disease	disease of metabolism (implicated_via_orthology)	PFKM PFKP PKM	1.30e-03	21	308	3	DOID:0014667 (implicated_via_orthology)
Disease	schizophrenia (is_implicated_in)	CACNA1I ANK3 NTRK1 GRIA4 GRIN2B	1.36e-03	78	308	5	DOID:5419 (is_implicated_in)
Disease	neutrophil count	HIVEP1 MAST2 FANCA JAK2 EPS15L1 PTPRC F11R TELO2 ATXN1 PKD1 TLN2 RPRD2 ADGRF5 PLCB4 DOCK6 PRUNE2 BIN1 JADE2 NTRK1 POU5F1 REST PSTPIP1 SLC45A4 MST1R ANKRD11 TRAF3IP3 HYDIN	1.42e-03	1382	308	27	EFO_0004833
Disease	total lipids in lipoprotein particles measurement	LIPG DOCK6 PCSK9 APOE	1.58e-03	48	308	4	EFO_0022309
Disease	contactin-1 measurement	PGAP6 MUC19	1.58e-03	6	308	2	EFO_0020286
Disease	Congenital muscular dystrophy (disorder)	SYNE2 LAMA2	1.58e-03	6	308	2	C0699743
Disease	Sensory Neuropathy, Hereditary	SCN9A NTRK1	1.58e-03	6	308	2	C0699739
Disease	Tumor of Rete Testis	DMRT1 ATF7IP	1.58e-03	6	308	2	C1720811
Disease	Familial erythrocytosis	JAK2 EPAS1	1.58e-03	6	308	2	cv:C0152264
Disease	stearoyl sphingomyelin (d18:1/18:0) measurement	SYNE2 APOE	1.58e-03	6	308	2	EFO_0800611
Disease	heart septal defect	WDR7 YTHDC2	1.58e-03	6	308	2	MONDO_0002078
Disease	age at first birth measurement	PRRC2A SDK1 JADE2 KCNH3 MST1R CNTN3	1.66e-03	120	308	6	EFO_0009101
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	HIVEP1 FANCA PLA2G6 CAMTA1 PRRC2A ZCCHC8 MST1R PACS1 MACF1 PATJ NFAT5	1.67e-03	364	308	11	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	apolipoprotein B to apolipoprotein A1 ratio	LIPG DOCK6 PCSK9 CEACAM20	1.70e-03	49	308	4	EFO_0021897
Disease	hair color	SP2 IL16 ZFYVE16 MAP3K1 FANCA KCNH1 AHNAK SYNE2 TACC1 ANKRD11	1.70e-03	311	308	10	EFO_0003924
Disease	level of Sphingomyelin (d40:2) in blood serum	SYNE2 PCSK9 ANKRD17	1.71e-03	23	308	3	OBA_2045181
Disease	clinical and behavioural ideal cardiovascular health	PCSK9 APOE NFAT5	1.71e-03	23	308	3	EFO_0007654
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	LIPG SYNE2 PCSK9 LLGL1 MACF1 CEACAM20	1.74e-03	121	308	6	EFO_0008595, EFO_0020943
Disease	sleep duration, high density lipoprotein cholesterol measurement	LIPG COBL DOCK6 APOE AFAP1 MACF1	1.74e-03	121	308	6	EFO_0004612, EFO_0005271
Disease	Disorder of eye	SMOC1 NPHP4 ALMS1 MERTK USH2A EYS VCAN GUCY2D	1.82e-03	212	308	8	C0015397
Disease	stomach carcinoma (is_marker_for)	ERBB4 KMT2C MDC1	1.94e-03	24	308	3	DOID:5517 (is_marker_for)
Disease	HDL cholesterol change measurement	SYNE2 DOCK6 APOE	1.94e-03	24	308	3	EFO_0007805
Disease	Sjogren's syndrome (is_marker_for)	MUC19 MUC16 CD40LG	1.94e-03	24	308	3	DOID:12894 (is_marker_for)
Disease	loneliness measurement	ERBB4 HIVEP1 FNBP4 MACF1 PRKG1 CDC25A	1.97e-03	124	308	6	EFO_0007865
Disease	puberty onset measurement	SNAP91 CAMTA1 JADE2 PRPF40A NFAT5 EPAS1	2.05e-03	125	308	6	EFO_0005677
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	TRAF3IP2 ERBB4 HIVEP1 ALMS1 PRPF40B CAMTA1 USH2A SDK1 NDUFAF2 JADE2 LAMA2 GRIA4 REST CNTN3 BICRAL IGSF9B PRKG1 NFAT5	2.06e-03	801	308	18	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	melanoma	FANCA HMCN2 PLA2G6 EYS ANKRD11 CNTNAP4	2.13e-03	126	308	6	EFO_0000756

Protein segments in the cluster

Peptide	Gene	Start	Entry
EFSDTNAAVEGTPLP	TACC1	246	O75410
GPSPQTVSASAEENI	BEST3	561	Q8N1M1
SNESGSPFDPVFEVE	ADNP	886	Q9H2P0
PAVEGPVSAQASSAT	AMOTL2	291	Q9Y2J4
STIPEAPVAQGATAE	ERBB4	1086	Q15303
STPVSQLGSADFPEA	EPS15L1	796	Q9UBC2
STQSEAGSLPAFTVP	EPAS1	446	Q99814
DSISPGELPNTFFTT	CDX4	251	O14627
IVPLSSQQDSGFDSP	CEP152	1691	O94986
SLSPVGSPVSEIAFE	CAMTA1	1471	Q9Y6Y1
PVQAVPEGEAARTST	ELF1	391	P32519
VQAAVGTSAAPVPSD	APOE	301	P02649
DSLVGQSFIPSSVPA	AP2B1	661	P63010
PTPAVVSSGLNDLFE	AP2B1	681	P63010
AVVTVTPSPEGVFSS	ANKRD11	1871	Q6UB99
VDAVPAAISTSEAAP	ANKRD11	2041	Q6UB99
SGTVSTNFPQTIEPA	VCAN	2081	P13611
LQPGASVFVNVTDPS	CD40LG	231	P29965
SATVSSPGSVPEVQD	C4B	406	P0C0L5
SFKVVGSFDEVPPTS	AADAC	61	P22760
GSFDEVPPTSDENVT	AADAC	66	P22760
PTAEGSQFPISTTIN	ADGRG4	1886	Q8IZF6
PSPFGDVSSRLTTEQ	AKIRIN2	66	Q53H80
TSDTEGPVPVNSAAV	AFAP1	686	Q8N556
ESEFAVQAPGSPLVA	AFF2	241	P51816
ATQSEDVVLPVFGTP	CEACAM20	41	Q6UY09
DSFPGAVVSISDQPT	FAM106A	116	Q4KMX7
GSAEPFVLPASSVES	FBXO34	526	Q9NWN3
PGFSSFSEIITTPTE	ADGRE5	46	P48960
VVSFAPSSNGTPEVE	ADGRG2	56	Q8IZP9
SVASEPVDQTTGTPA	ALMS1	1266	Q8TCU4
VVPNTSFAPATVSQG	ARID2	1176	Q68CP9
TSSFAASGPLIPEEN	AP4B1	591	Q9Y6B7
SPTVVTFSFDVGNGP	CNTNAP4	846	Q9C0A0
SFGISAPQVSIPDVN	AHNAK	5186	Q09666
ETTPTVVGAVSAPAE	AQR	1456	O60306
LDFESSGSSEPPAQV	C8orf58	91	Q8NAV2
LSSVPSEAQISDPFA	SNAP91	391	O60641
VDTPAEQFLQPSTSS	DCAF6	401	Q58WW2
VASSSEQEAGSPPVV	ANKRD17	2071	O75179
ASGAAPAIVTSSPQF	ATXN1	501	P54253
DQTFCGTGPVSEPET	CPO	201	Q8IVL8
AFNSVDPTFDNSVPS	DNAJC2	156	Q99543
PPFDFSLESSTSEVQ	DSC2	606	Q02487
DVFSDSASVVAPLAP	AP2A2	686	O94973
SASVVAPLAPGSEDN	AP2A2	691	O94973
TPAAADVNGSPATIT	GMEB2	201	Q9UKD1
ESFPAQVPSGEDQTA	NFE2L1	236	Q14494
TTSVPGSPDGVFDQT	R3HCC1L	266	Q7Z5L2
NIQTFSTASVGTAPP	RBM12	146	Q9NTZ6
DGDFTFSSPQVVTQP	RANBP2	1041	P49792
LDSFGNLDVSPPVTV	PADI1	406	Q9ULC6
QEASFTVTVPPSEGS	HSPG2	3001	P98160
PPTAVSIEGVVADTS	RBMS3	386	Q6XE24
SVESAVDTPFPAGIF	RARRES2	51	Q99969
APGQDVTLFRSPDSV	QRICH2	981	Q9H0J4
ADTSVEEESFGPQPI	RAD51	11	Q06609
SPSLQTFAPEADGTI	ARHGAP39	251	Q9C0H5
ESPVALGESASVPQV	RIMBP3B	751	A6NNM3
ESPVALGESASVPQV	RIMBP3C	751	A6NJZ7
PFISSGTTVPQTSVD	IQCH	781	Q86VS3
VFRTNGVSDVPTSPT	JAK2	511	O60674
ISNSELFPTTDPVGT	OXSR1	366	O95747
RTGPAEPVSQAEATS	KCNH3	1026	Q9ULD8
VDAGSFPTLQPTVAT	LLGL1	266	Q15334
EIVPSASLDTFPSEN	ANKS1B	436	Q7Z6G8
LSATAAPQTPDSDIF	RABGAP1	276	Q9Y3P9
APQTPDSDIFTFSVS	RABGAP1	281	Q9Y3P9
LEVAAAPSVTPQAGT	HCFC1	1391	P51610
SGFETQSAPGPVSVV	MUC16	1406	Q8WXI7
EDVTSIPGPAQSTIS	MUC16	7866	Q8WXI7
EASSAVLTVSPEVPG	MUC16	11136	Q8WXI7
SGRDISATFPTVPES	MUC16	11326	Q8WXI7
PAETSTTVSGTIPNF	MUC16	11581	Q8WXI7
PVTSAALVTFDPEGQ	MUC4	291	Q99102
PSGTVSQETFPSGET	MUC4	361	Q99102
DVSSASTGQATPLPV	MUC4	1701	Q99102
ESVPEEAPGFSNTSL	NUP133	581	Q8WUM0
DSFIQAKSTGTEPPA	PSTPIP1	266	O43586
FLSADGSPQVSEAAP	DCHS1	366	Q96JQ0
ASSEATIRENAPPGT	DCHS1	2071	Q96JQ0
LSVVEPQPVFEASGA	REST	116	Q13127
VESIPEGLDFPNAST	PLD3	86	Q8IV08
DSFPGAVVSISDQPT	FAM106C	116	P0CH98
IPVSFSPVDTNSTSG	NTRK1	391	P04629
AEGPAAQTTAEPSRS	PASK	26	Q96RG2
SSPVRNLQSFGTEEP	KAT7	56	O95251
TGPPSRDDFSEVLTQ	PIP5KL1	76	Q5T9C9
FVPSSSPESVVGVEV	KMT2C	4001	Q8NEZ4
DNGRDVTSVEPPSVS	LRP12	706	Q9Y561
QEAAVSSSSPLVPGT	MAGEA4	36	P43358
AASDLEPFTPTDQSV	MDC1	1656	Q14676
EGFAQSSLQIPVSPS	MAGEC1	261	O60732
SSPERTQSTFEGFPQ	MAGEC1	286	O60732
GVPFRNVDNDSPTSV	MAGEC2	6	Q9UBF1
PLTGSVPDFSEVTTN	EYS	1776	Q5T1H1
SVTFPVVASGEPVSV	GREB1	356	Q4ZG55
ASTTEGAPSVAPLNV	MERTK	376	Q12866
VSTEFQSPQVAGIPA	FSCB	756	Q5H9T9
QAEGTTAPAVTPAAD	GUCY2D	156	Q02846
TTESAAPDATVGTPL	MUC20	486	Q8N307
PTNSATEREVTAPGA	MUC20	501	Q8N307
DIGPVTLTADPTVFQ	HMCN2	86	Q8NDA2
PITTATTTQEPAGAA	KATNIP	396	O60303
IIPSVASPTDTSNFD	PRKG1	636	Q13976
PSNVTSLVGSQFSEP	KIAA2026	1856	Q5HYC2
PTVASQPISFEISIG	FER1L4	441	A9Z1Z3
QDVTLAPATEPASGS	MUC1	76	P15941
ISDVSVSDVPFPFSA	MUC1	1136	P15941
SPPQNFTVIFDTGSS	CTSE	86	P14091
SVAADSDVQVPGPAA	JADE2	686	Q9NQC1
FAEQSIPDTTFTSVP	KCNV1	366	Q6PIU1
SLITPSFPTEGESQF	GRIA4	116	P48058
SPASAPEVITVGATN	PCSK9	326	Q8NBP7
PIDDVQGSFQPTVVS	PCYOX1L	321	Q8NBM8
IASVVVTPPDSNDGT	FAT2	256	Q9NYQ8
QAGTSEVAPSTTVAP	MUC19	6951	Q7Z5P9
EVAPSTTVAPGSFST	MUC19	6956	Q7Z5P9
PATVSNNVPGSDFSV	PFKM	526	P08237
PATVSNNVPGSDFSI	PFKP	536	Q01813
FTSQPSGEAEAPQTT	PEAK1	821	Q9H792
ESVFLPSEGSNLTPA	PIP5K1B	61	O14986
RPVSSTGINFDNPSV	NCOA5	526	Q9HCD5
VQLADTSEAGPSSVP	IL16	61	Q14005
SFSPNTESQIGPEEA	KIF1C	426	O43896
TPVSFQAASTSGVPD	KCNH1	796	O95259
VPEGTAAVAAVSSPE	MACF1	916	O94854
AAVAAVSSPEETAPA	MACF1	921	O94854
VSSPEETAPAVAAAI	MACF1	926	O94854
VPTPAESASFAAVVA	MACF1	1176	O94854
TFCTEDPENTSISPG	LIPG	461	Q9Y5X9
PASATAPTEAAQIIS	IMMT	136	Q16891
VALSAEATPATTGVP	NUP214	1561	P35658
EATPATTGVPDARTE	NUP214	1566	P35658
TSIVAPGPSAEAAAF	NUP214	1621	P35658
TAPSATPVFGQVAAS	NUP214	1666	P35658
TPVFGQVAASTAPSL	NUP214	1671	P35658
LAPITSDPTEATAVG	PKM	401	P14618
PVPIDVGTEINLSFS	LAMA2	2541	P24043
SDSEFSSPEVQGPII	MOCOS	376	Q96EN8
SATPAQGEETVPEAV	LRRC46	251	Q96FV0
SFPDDTAVQPSFQVG	PGAP6	116	Q9HCN3
RVFSGSAVPAPEEES	PNMA2	166	Q9UL42
PAALTSDAEQPSGFT	NOL8	1031	Q76FK4
LALVDAGFTTSVVPP	OR2I1P	66	Q8NGU4
DSFGNLEVSPPVTVN	PADI2	406	Q9Y2J8
LSSEFGAPVSVPVQE	PELP1	326	Q8IZL8
IPPGESSESVFSQAT	ITPRID2	1096	P28290
QDISQPGTFPAVSAS	NFAT5	681	O94916
VESIFFPSEGSNLTP	PIP5K1A	116	Q99755
SVAGSLPDTFNDASP	MYOCD	466	Q8IZQ8
PAEAVSATEPVTFNP	NPHP4	616	O75161
DGDDSPVVSLTVPST	PACS1	766	Q6VY07
EGEAFPPVSVTTLGS	POU5F1	341	Q01860
APVSQAAVSDASLGP	FAM182B	116	Q5T319
SVVTRTGEQAPASAP	PTPRS	416	Q13332
SASNTVSGTVPVVPE	PRPF40A	301	O75400
PVSGSVTIPVLFNES	FAM171A2	611	A8MVW0
EAEGSEQSPSPTQLF	HOXB8	121	P17481
TSITLDVGPESFNPG	PALB2	96	Q86YC2
TVVTQEPSFSVSPGG	IGLV8-61	26	A0A075B6I0
FPGSQTSDTLPEVSA	PGR	36	P06401
ITFEPQDVEVPSGNT	PXDNL	236	A1KZ92
FGEFLNSDSVTVPPS	GAK	981	O14976
LTGESEPQTRSPEFT	ATP1A2	216	P50993
SAEPDGPLNVNVFTS	EVA1B	101	Q9NVM1
RSSNIPAGDSVPEFV	IGSF22	56	Q8N9C0
PSQFVVPANSEGTFS	HYDIN	4876	Q4G0P3
ESSSANVSPFAPGVS	HEATR5B	1116	Q9P2D3
NVSPFAPGVSSRTDI	HEATR5B	1121	Q9P2D3
NVTEDFSFSEPLPNT	BLM	66	P54132
FGNSSSSPVAQPVTV	BICRAL	266	Q6AI39
SDPTVSGSVELDFPN	BICRAL	1026	Q6AI39
DLDTTPVVNGFASVP	CYP2C19	466	P33261
ISSSNPDLAVAPGSV	DOCK6	881	Q96HP0
NEEGPTTNVEPFFVT	DOCK9	386	Q9BZ29
SVTDLPNAFDGPITI	CD44	131	P16070
VPNVFPSSGDFTQTA	FBXL4	81	Q9UKA2
DAFNLETPSGPESSV	DYTN	536	A2CJ06
NTTGVPASLPVEFTI	FLNA	1556	P21333
QSEPLTGVFTTEEVP	COL14A1	611	Q05707
QLFVAGDTSTVSPPA	FANCA	1366	O15360
TFSPIEFQIGETPLS	BORA	276	Q6PGQ7
SAAAPAAEPGVTTEQ	CACNA1I	11	Q9P0X4
PPTIANGDFTSISRE	CR1L	161	Q2VPA4
SLSSSVPEAESQPIG	COBL	751	O75128
PEDTSPGTQVLAVFA	FAT3	3246	Q8TDW7
SAAFPSDATAEQGPI	ILF3	506	Q12906
SGLASSSVPANEVPA	HOXD13	171	P35453
TVTDVNDNPPEFTAS	CDH4	381	P55283
TFSPQGLAQPDSVSI	CCL8	16	P80075
STTVPLVQASFPEGA	ANK3	1156	Q12955
PVEIGSDPTAFSVLT	ANKMY2	291	Q8IV38
SQTTFGPVFEDQPLS	CNTN2	31	Q02246
SSATPQETLISDGPF	CCP110	191	O43303
FSEEPVSENLSPNTT	FAM169A	551	Q9Y6X4
SGNVEFISVQSPPTV	ATF7IP	811	Q6VMQ6
PFITSSPTNGAETVA	MANBA	501	O00462
APETTAVSAETGPEV	MGARP	146	Q8TDB4
PQAIEEAASSSSAGP	MAST2	1586	Q6P0Q8
PTPQAVATEGVFVTE	DNAAF1	511	Q8NEP3
VPTFPTQGVEESAET	ENO4	606	A6NNW6
DFSPVQTSQGASDPL	FOXM1	636	Q08050
EQAALAAVTPSPTSA	CPEB1	236	Q9BZB8
SAAAPASVETPLNSV	ENAH	266	Q8N8S7
DFPAGVVPVTTVTAE	FAAH	501	O00519
NLDTTPVVNGFASVP	CYP2C9	466	P11712
TGVAPDTPFVINSAT	CELSR3	691	Q9NYQ7
SEDAPPFTSVLQISA	CELSR3	971	Q9NYQ7
SQADVAVFEAVSSPP	EEF1B2	31	P24534
PAVVVETFPATVNGT	BIN1	491	O00499
VTGNPVPASEAASQS	RPRD2	546	Q5VT52
PSAAPENVSAEAVSS	SDK1	1276	Q7Z5N4
NIIGESPASAPVEVF	SDK1	1681	Q7Z5N4
SPASAPVEVFVGEAA	SDK1	1686	Q7Z5N4
AGPQAEESATVSAPA	SCNM1	166	Q9BWG6
APVGAQASAAPTSVD	SALL3	611	Q9BXA9
EGPFSPVTTVFSAEE	CNTN3	786	Q9P232
FSAEEEPTVAPSQVS	CNTN3	796	Q9P232
PIVPTAEFQDSISGA	GLUD2	486	P49448
FSTSPGQESPVESFI	MFSD5	331	Q6N075
SATVSSPGSVPEVQD	C4A	406	P0C0L4
ASVFSPPSSQDSGLV	DMRT1	321	Q9Y5R6
NDISFGTSAVTPDIP	LRRC8D	96	Q7L1W4
TGQPIVFSQPESDEA	NUBPL	286	Q8TB37
FTPQSPVTATLSDED	CDC25A	201	P30304
QVESESSVLNDSPFP	MPHOSPH8	261	Q99549
SQVPFETRGPNVDSS	MTMR3	831	Q13615
VLAEGVSSPAPTQDT	PKD1	3476	P98161
SFVTVSIPENNSPGI	PCDH11Y	501	Q9BZA8
TESPIDFVVTDTVPG	PELI1	106	Q96FA3
NPTTGELVFDPLSAS	F11R	191	Q9Y624
ADVFPATTGAVSTPV	MUC17	3951	Q685J3
SSNAVIPSDETVFTP	MAP3K1	1101	Q13233
PDTPFTAIAGSEIFS	RUVBL2	96	Q9Y230
SGTLVDANSNSPAVP	RUSC1	56	Q9BVN2
PLRVSVGDSSQEFSP	RUSC2	561	Q8N2Y8
VETSAASEFPQAPIG	RTL3	216	Q8N8U3
QVETSPTFSDKGVPF	HSF5	241	Q4G112
LAATEAQTTPPAATE	SELPLG	166	Q14242
FLFDPQGSPVEVTTT	USH2A	1581	O75445
AAPAGKTSSVFEDPV	MRPS7	76	Q9Y2R9
PVTPITNFEGSQSQD	STRADA	396	Q7RTN6
EFLSVATTAPGPQQV	PHTF2	16	Q8N3S3
PINSDSTESVPQFTD	SERTM2	66	A0A1B0GWG4
TFDPFSETPVDGVIA	PLCB4	686	Q15147
ISDSFSPESQPGARA	PRUNE2	2251	Q8WUY3
PQQIPIDSTVSFGAS	PPP1R8	106	Q12972
VPESSGAVETVPAFQ	SYNE2	3541	Q8WXH0
SAVAAPVLGAEQSSP	TMEM200C	561	A6NKL6
TTAAASPSVSVIPEG	TMEM184B	16	Q9Y519
PSSVPGAETSFVVNT	FNBP4	261	Q8N3X1
TPGIFDTEVPNAETS	GIMAP4	86	Q9NUV9
ESPVALGESASVPQV	RIMBP3	751	Q9UFD9
TGVVTSVPSDSPDDI	LARS1	386	Q9P2J5
SAPVSAQPVDASVGL	SLC2A8	356	Q9NY64
SVTSFSPDDVASPQG	PRR36	1321	Q9H6K5
PVQDSSPGTDQAEFT	FSD2	411	A1L4K1
ASAPGPEEALTTVTV	PRRC2A	1281	P48634
INTTDGSRFPASQVP	SCN9A	1351	Q15858
VTTSDIPGSPEEASV	SHISAL2A	166	Q6UWV7
EFNPFSETNAATTVP	SCAMP2	36	O15127
PEAAVSQPGSAVASD	TELO2	646	Q9Y4R8
TNPISEETTTFPTGG	SPESP1	91	Q6UW49
EETTTFPTGGFTPEI	SPESP1	96	Q6UW49
RVVDESFVDTSPTGP	POLR3H	151	Q9Y535
VDTPNDFGETPTFLA	PLA2G6	376	O60733
DFGSTGPQSIPAVSI	TSC22D1	521	Q15714
PAPASTQSVLADGTD	FAM13C	181	Q8NE31
PAPQEATATFNSTAD	ICAM2	166	P13598
DPVGPFGQESVTSVT	MED13	641	Q9UHV7
GNSQPPDVFVSSVAE	SYCE2	186	Q6PIF2
QVDEETFSVFAPTPS	PNPT1	641	Q8TCS8
TFSAAEESVVPPASL	SVEP1	1166	Q4LDE5
SSFTNKIPDEGDTTP	RASGRF1	806	Q13972
QSFSQPGELPEDAVS	EXTL1	56	Q92935
ELEQPFAQDTSSVGP	SAFB	236	Q15424
PVGLEPAVEQSSAAS	SAFB	311	Q15424
TPDPISVSEGQNFSI	ADGRF5	476	Q8IZF2
SVAQAPAGTSFVAPV	ANKHD1	2381	Q8IWZ3
GPRLPSSVAQTVDDF	CEP164	1341	Q9UPV0
AVSEPASESVVGALP	TRAF3IP2	121	O43734
PSSEVTGPTFTENSV	ZBTB25	221	P24278
VFSGTASPSPGEETF	PNMA5	161	Q96PV4
VIFEGDPKAPSNSTA	SLC45A4	536	Q5BKX6
SLTFSVVTGPAPSQE	TGM2	56	P21980
PAQAAETTAESPVSL	ZNF750	466	Q32MQ0
SPREQVTGTSSEVFP	TRAF3IP3	111	Q9Y228
EEQPVASTPTTVSDG	TMX2	276	Q9Y320
ETQPVFDGDEITAPT	SMOC1	186	Q9H4F8
ATVSGSPEAPGTNVV	UBXN6	91	Q9BZV1
SDVPVDTPLTGNSVA	ZCCHC8	541	Q6NZY4
FTQPATDGLSEPDVF	nan	111	Q6ZSR9
PVSATAAGPEASFEA	ZBP1	291	Q9H171
NAVFPEELGTSVPLT	PHIP	1126	Q8WWQ0
SPASVVAPGTTLFEE	SLC9A2	51	Q9UBY0
ASRGPNSVSEISEAP	TRO	306	Q12816
DFIVSATGVTPNVEP	PYROXD1	311	Q8WU10
EPSNIAGVSSTDIFP	IGSF9B	696	Q9UPX0
AGVSSTDIFPQPDLT	IGSF9B	701	Q9UPX0
PPALFLTGAVETETN	PATJ	476	Q8NI35
DSLPPSTGTFQEAQS	TLN1	1226	Q9Y490
RLQPVNSTFSPGDES	TTYH2	26	Q9BSA4
VLVQDSPPATAAATS	SP2	366	Q02086
SASPSVQGAPREVVD	WASH4P	356	A8MWX3
SPNVELSFPQRSEGS	WBP2NL	26	Q6ICG8
TQFSTLDGDVEAPPS	PIEZO2	1816	Q9H5I5
TSSLSEDQVPGPFLV	PIEZO2	2221	Q9H5I5
NSSVPPAGAEELSSA	ZDBF2	2271	Q9HCK1
AVSTTARGQTPFPDA	TMPRSS9	791	Q7Z410
SASPSVQGAPREVVD	WASH3P	341	C4AMC7
EEPSVAPSSTGKTFQ	NDUFAF2	141	Q8N183
TPTFDSEVAPSFGTL	NUP188	1596	Q5SRE5
ITFPPAGSQTVSAAA	STAM2	141	O75886
VPVTAATAPGADTAS	PRPF40B	71	Q6NWY9
LEQPFAQDTSSVGPD	SAFB2	236	Q14151
ALDASAPIEQPSFVS	SUCO	176	Q9UBS9
VPVSAAGSANETPEI	TOMM6	6	Q96B49
INIAPVDGIPASFTS	PLAAT1	41	Q9HDD0
PPTVKFGNSTTFQDD	SAXO2	106	Q658L1
VFSPESEVSAPGVSE	ZNF827	616	Q17R98
AQPPEFDSGVETFSI	TJP1	1581	Q07157
EPSSFRVDGIPNDSS	YTHDC2	1076	Q9H6S0
PEFVSIPAQISSEGS	TLN2	1581	Q9Y4G6
IEAGTFSSDLQTPRP	ZDHHC8	321	Q9ULC8
TEAPASPSTQEAIQG	PHF8	746	Q9UPP1
TTAAAPGEETSPVQV	SNAPC4	616	Q5SXM2
PVFSEAEGTAPAASQ	SNAPC4	991	Q5SXM2
SQSPAEADGSVAFVP	SNAPC4	1161	Q5SXM2
SEVPEVTPSENVGSS	ZNF148	576	Q9UQR1
NVSAEGQDLSPVSPF	VSIG10L	96	Q86VR7
FPASVVSSEGQVPNL	LCMT2	341	O60294
PTDNASVTGTPVVSE	WWP1	251	Q9H0M0
DPSTLENSSAFEGVP	XKR5	461	Q6UX68
PPSTGFGVTQETEFS	VWA8	1316	A3KMH1
GFVLPNAEDIISSPS	TTLL4	936	Q14679
PFDTSSPQAGRQLET	ZHX3	941	Q9H4I2
APSLTSQVDFSAPDI	WDR91	516	A4D1P6
FLDTEVFVTGQSPTP	PTPRC	16	P08575
AQTITTAPDASGPEA	WDR7	1071	Q9Y4E6
VSDTVFDSIPANPAL	PKP2	226	Q99959
FLTVQPASVTDDPSA	MST1R	261	Q04912
SSFTPSSPENVIGDF	HIVEP1	531	P15822
TRAFGPSETNESPAV	SON	171	P18583
IPTVDASIPTSQNGF	VPS37A	206	Q8NEZ2
VFAETEEPSSPTGVL	ZFYVE16	971	Q7Z3T8
PAAFDTSVSAPSQGI	TMEM108	361	Q6UXF1
TFDPSSGQVEVQPSL	KLHL35	551	Q6PF15
NSSVGDSPAVPAETQ	KIAA0319	196	Q5VV43
IGNLSSPVSPVEASF	NACA	821	E9PAV3
RGTLENSNSPVPEFS	N4BP2	1166	Q86UW6
PTTQSEVSPLFAGTD	MYO9A	1776	B2RTY4
NGSTVATAASPAPEE	PPP1R9B	331	Q96SB3
LVAGDTDTVPAEFPT	GRIN2B	261	Q13224
TDTVPAEFPTGLISV	GRIN2B	266	Q13224
TVAVVFSSSGPPQAQ	GRIN2C	31	Q14957
APVDQFPGTAVESVT	NECAP2	71	Q9NVZ3